[
  {
    "Ref": "PHC0001",
    "Questions": "According to the Standard Treatment Guidelines and Essential Medicines List for South Africa Primary Healthcare Level 2020 Edition what is the first-line treatment for uncomplicated non-severe malaria at the PHC level?",
    "A": "Artemether/lumefantrine",
    "B": "Quinine",
    "C": "Doxycycline",
    "D": "Mefloquine",
    "Answer": "A",
    "Comment": "The guideline states that artemether/lumefantrine is the recommended first-line treatment for uncomplicated malaria, to be taken with fat-containing food for adequate absorption[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0002",
    "Questions": "What is the recommended treatment for impetigo in a patient with no known drug allergies?",
    "A": "Topical mupirocin",
    "B": "Oral penicillin V",
    "C": "Oral amoxicillin",
    "D": "Topical chloramphenicol",
    "Answer": "A",
    "Comment": "Topical mupirocin is recommended for limited impetigo[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0003",
    "Questions": "Which of the following is the standard prophylaxis for an HIV-exposed infant?",
    "A": "Cotrimoxazole from birth",
    "B": "Nevirapine at birth",
    "C": "Zidovudine from birth",
    "D": "Cotrimoxazole from 6 weeks of age",
    "Answer": "D",
    "Comment": "The guidelines state that cotrimoxazole prophylaxis for HIV-exposed infants should be initiated from 6 weeks of age[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0004",
    "Questions": "According to the guidelines which of the following is a risk factor for severe COVID-19 disease?",
    "A": "Being elderly",
    "B": "Being a healthcare worker",
    "C": "Being a teenager",
    "D": "Being a vegetarian",
    "Answer": "A",
    "Comment": "The guidelines identify the elderly as being at high risk for severe COVID-19 disease[cite: 7].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0005",
    "Questions": "What is the correct treatment for an acute gout attack?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Probenecid",
    "D": "Indomethacin",
    "Answer": "B",
    "Comment": "The guidelines recommend colchicine as the treatment for acute gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0006",
    "Questions": "A patient presents with acute, uncomplicated cystitis. Which of the following is a recommended treatment?",
    "A": "Ciprofloxacin",
    "B": "Trimethoprim/sulfamethoxazole (Co-trimoxazole)",
    "C": "Amoxicillin/clavulanic acid",
    "D": "Nitrofurantoin",
    "Answer": "D",
    "Comment": "Nitrofurantoin is a recommended treatment for acute, uncomplicated cystitis[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0007",
    "Questions": "What is the recommended first-line treatment for scabies?",
    "A": "Permethrin 5% cream",
    "B": "Calamine lotion",
    "C": "Benzyl benzoate 25% lotion",
    "D": "Oral ivermectin",
    "Answer": "C",
    "Comment": "Benzyl benzoate 25% lotion is recommended as the first-line treatment for scabies[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0008",
    "Questions": "Which of the following is a sign of severe malaria?",
    "A": "Mild fever",
    "B": "Headache",
    "C": "Muscle and joint pains",
    "D": "Jaundice",
    "Answer": "D",
    "Comment": "The guideline lists jaundice as a clinical feature of severe malaria[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0009",
    "Questions": "According to the guidelines what is a key instruction for a patient on chronic therapy?",
    "A": "Take medication when symptoms appear",
    "B": "Stop medicine when feeling better",
    "C": "Inform other healthcare providers about all conditions and medicines",
    "D": "Adjust doses as needed without consulting a doctor",
    "Answer": "C",
    "Comment": "The guideline states that every patient on chronic therapy must inform other healthcare providers about any other condition/disease and its management when seeking medical attention for other complaints[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0010",
    "Questions": "What is the recommended first-line oral therapy for a child with tinea capitis?",
    "A": "Topical clotrimazole",
    "B": "Oral griseofulvin",
    "C": "Topical ketoconazole",
    "D": "Oral fluconazole",
    "Answer": "B",
    "Comment": "Oral griseofulvin is the recommended first-line treatment for tinea capitis in children[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0011",
    "Questions": "What is the first-line treatment for a patient with an acute dental abscess at a PHC level?",
    "A": "Oral amoxicillin",
    "B": "Oral penicillin V",
    "C": "Topical antiseptic",
    "D": "Referral for drainage and antibiotics",
    "Answer": "D",
    "Comment": "The guidelines recommend referral for drainage and antibiotics as the first line of management for a dental abscess[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0012",
    "Questions": "What is the recommended treatment for herpes simplex infections of the mouth and lips?",
    "A": "Oral aciclovir",
    "B": "Topical aciclovir",
    "C": "Oral antibiotic",
    "D": "Oral antiviral therapy",
    "Answer": "A",
    "Comment": "The guideline suggests oral aciclovir for herpes simplex infections of the mouth and lips[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0013",
    "Questions": "What is the recommended treatment for an adult with an uncomplicated urinary tract infection?",
    "A": "Trimethoprim",
    "B": "Ciprofloxacin",
    "C": "Nitrofurantoin",
    "D": "Cefalexin",
    "Answer": "C",
    "Comment": "Nitrofurantoin is a recommended first-line agent for uncomplicated urinary tract infection in adults[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0014",
    "Questions": "Which of the following is the recommended treatment for moderate persistent diarrhoea in a child?",
    "A": "Oral rehydration solution (ORS) only",
    "B": "Ciprofloxacin",
    "C": "Zinc sulphate",
    "D": "Oral antibiotic",
    "Answer": "C",
    "Comment": "The guideline recommends zinc sulphate as an adjunct to ORS for persistent diarrhoea in children[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0015",
    "Questions": "Which of the following is a key component in the management of Chronic Kidney Disease (CKD) at the PHC level?",
    "A": "Dialysis",
    "B": "ACE-inhibitors",
    "C": "Surgical intervention",
    "D": "Immunosuppressants",
    "Answer": "B",
    "Comment": "The guideline states that ACE-inhibitors are used in the management of Chronic Kidney Disease[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0016",
    "Questions": "Which of the following is the correct management for uncomplicated gingivitis?",
    "A": "Chlorhexidine mouthwash",
    "B": "Systemic antibiotics",
    "C": "Surgical debridement",
    "D": "Pain medication only",
    "Answer": "A",
    "Comment": "Uncomplicated gingivitis is managed with chlorhexidine mouthwash[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0017",
    "Questions": "What is the recommended first-line treatment for chronic anal fissure?",
    "A": "Topical antibiotic",
    "B": "Bulk-forming laxatives",
    "C": "Topical anaesthetic",
    "D": "Oral painkiller",
    "Answer": "B",
    "Comment": "Bulk-forming laxatives are recommended as the first-line treatment for chronic anal fissure[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0018",
    "Questions": "Which medicine is recommended for the treatment of uncomplicated bacillary dysentery?",
    "A": "Ciprofloxacin",
    "B": "Metronidazole",
    "C": "Azithromycin",
    "D": "Amoxicillin",
    "Answer": "C",
    "Comment": "The guideline recommends azithromycin as a treatment for bacillary dysentery[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0019",
    "Questions": "What is the recommended treatment for a patient with taenia (tapeworm) infestation?",
    "A": "Albendazole",
    "B": "Praziquantel",
    "C": "Mebendazole",
    "D": "Metronidazole",
    "Answer": "B",
    "Comment": "The guideline recommends praziquantel for the treatment of tapeworm infestation[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0020",
    "Questions": "What is the primary intervention for a patient with acute diarrhoea without blood?",
    "A": "Oral rehydration solution (ORS)",
    "B": "Loperamide",
    "C": "Oral antibiotics",
    "D": "Intravenous fluids",
    "Answer": "A",
    "Comment": "The primary intervention for acute diarrhoea is oral rehydration solution (ORS)[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0021",
    "Questions": "What is the recommended treatment for oral candidiasis (thrush)?",
    "A": "Nystatin oral suspension",
    "B": "Oral fluconazole",
    "C": "Oral amphotericin B",
    "D": "Topical chlorhexidine",
    "Answer": "A",
    "Comment": "Nystatin oral suspension is the recommended treatment for oral thrush[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0022",
    "Questions": "According to the guidelines what is the most common cause of treatment failure in malaria?",
    "A": "Vomiting the oral treatment",
    "B": "Using the wrong dose",
    "C": "Taking the medicine at the wrong time",
    "D": "Not taking the full course",
    "Answer": "A",
    "Comment": "The guideline states that vomiting oral treatment is one of the commonest reasons for treatment failure in malaria[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0023",
    "Questions": "What is the recommended management for a child with uncomplicated Severe Acute Malnutrition (SAM)?",
    "A": "Admission to hospital",
    "B": "Outpatient care with RUTF",
    "C": "Oral antibiotics",
    "D": "Intravenous fluids",
    "Answer": "B",
    "Comment": "Uncomplicated SAM is managed on an outpatient basis with ready-to-use therapeutic food (RUTF)[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0024",
    "Questions": "What is the first-line antihypertensive medication recommended for a patient with hypertension and diabetes mellitus?",
    "A": "Amlodipine",
    "B": "Hydrochlorothiazide",
    "C": "ACE-inhibitor",
    "D": "Atenolol",
    "Answer": "C",
    "Comment": "ACE-inhibitors are the first-line therapy for hypertension in adults with diabetes[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0025",
    "Questions": "What is the recommended treatment for a patient with post-herpes zoster neuropathy?",
    "A": "Acyclovir",
    "B": "Amitriptyline",
    "C": "Ibuprofen",
    "D": "Carbamazepine",
    "Answer": "B",
    "Comment": "The guideline states that amitriptyline is recommended for post-herpes zoster neuropathy[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0026",
    "Questions": "Which of the following is NOT a first-line treatment for hypertension in adults?",
    "A": "Thiazide diuretic",
    "B": "ACE-inhibitor",
    "C": "Beta-blocker",
    "D": "Angiotensin II Receptor Blocker (ARB)",
    "Answer": "C",
    "Comment": "The guideline states that beta-blockers are NOT a first-line treatment for hypertension, unless there are co-morbidities[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0027",
    "Questions": "According to the guidelines what is a key management step for a patient with acute myocardial infarction (AMI)/ST-elevation myocardial infarction (STEMI) at the PHC level?",
    "A": "Immediate referral",
    "B": "Streptokinase",
    "C": "Aspirin",
    "D": "Nitroglycerin",
    "Answer": "A",
    "Comment": "The guidelines recommend immediate referral of a patient with an AMI/STEMI[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0028",
    "Questions": "Which of the following is recommended for the prevention of rheumatic fever?",
    "A": "Penicillin V",
    "B": "Amoxicillin",
    "C": "Erythromycin",
    "D": "Doxycycline",
    "Answer": "A",
    "Comment": "Benzathine benzylpenicillin is recommended for the prevention of rheumatic fever[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0029",
    "Questions": "What is the recommended treatment for a chronic leg ulcer caused by cellulitis?",
    "A": "Oral amoxicillin/clavulanic acid",
    "B": "Topical corticosteroids",
    "C": "Oral cefalexin",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends oral cefalexin as a treatment for chronic lower leg ulcers[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0030",
    "Questions": "Which is a recommended treatment for mild non-specific headache?",
    "A": "Aspirin",
    "B": "Ibuprofen",
    "C": "Paracetamol",
    "D": "Naproxen",
    "Answer": "C",
    "Comment": "Paracetamol is a recommended treatment for mild, non-specific headache[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0031",
    "Questions": "What is the first-line treatment for moderate acute malnutrition (MAM) in children?",
    "A": "Ready-to-use therapeutic food (RUTF)",
    "B": "F100",
    "C": "F75",
    "D": "Corn-soya blend",
    "Answer": "D",
    "Comment": "The guidelines state that corn-soya blend (CSB++) is the recommended treatment for moderate acute malnutrition (MAM)[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0032",
    "Questions": "What is the recommended management for an uncomplicated case of ringworm?",
    "A": "Oral griseofulvin",
    "B": "Topical clotrimazole",
    "C": "Topical mupirocin",
    "D": "Oral fluconazole",
    "Answer": "B",
    "Comment": "The guideline recommends topical clotrimazole for uncomplicated ringworm (tinea corporis)[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0033",
    "Questions": "What is the initial management for a patient with a boil or abscess?",
    "A": "Incision and drainage",
    "B": "Systemic antibiotics",
    "C": "Topical antibiotic",
    "D": "Oral painkiller",
    "Answer": "A",
    "Comment": "The guideline states that incision and drainage is the initial management for a boil or abscess[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0034",
    "Questions": "According to the guidelines what is a common treatment for atopic eczema?",
    "A": "Oral steroids",
    "B": "Topical corticosteroids",
    "C": "Oral antibiotics",
    "D": "Topical antifungals",
    "Answer": "B",
    "Comment": "Topical corticosteroids are a common treatment for atopic eczema[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0035",
    "Questions": "What is the recommended treatment for an adult with urticaria?",
    "A": "Oral antihistamine",
    "B": "Topical steroid",
    "C": "Oral steroid",
    "D": "Topical antibiotic",
    "Answer": "A",
    "Comment": "Oral antihistamine is the recommended treatment for urticaria[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0036",
    "Questions": "What is the recommended management for a patient with a suspected ectopic pregnancy at a PHC level?",
    "A": "Immediate referral for surgery",
    "B": "Oral analgesics",
    "C": "Methotrexate",
    "D": "Expectant management",
    "Answer": "A",
    "Comment": "The guideline states that all patients with a suspected ectopic pregnancy must be referred for a surgical assessment[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0037",
    "Questions": "What is the initial management for a patient with incomplete miscarriage in the first trimester?",
    "A": "D&C (Dilatation and Curettage)",
    "B": "Mifepristone and misoprostol",
    "C": "Misoprostol",
    "D": "Immediate referral",
    "Answer": "C",
    "Comment": "The guideline recommends misoprostol as the initial management for incomplete miscarriage in the first trimester[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0038",
    "Questions": "Which is a recommended antenatal supplement for all pregnant women?",
    "A": "Folic acid and iron",
    "B": "Vitamin A",
    "C": "Vitamin C",
    "D": "Calcium",
    "Answer": "A",
    "Comment": "The guideline states that folic acid and iron supplements are recommended for all pregnant women[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0039",
    "Questions": "What is the management of a patient with mild to moderate gestational hypertension?",
    "A": "Immediate delivery",
    "B": "Bed rest and observation",
    "C": "Labetalol",
    "D": "Magnesium sulphate",
    "Answer": "B",
    "Comment": "The guidelines recommend bed rest and observation for mild to moderate gestational hypertension[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0040",
    "Questions": "What is the recommended management for a patient with eclampsia?",
    "A": "Immediate delivery and magnesium sulphate",
    "B": "Bed rest and observation",
    "C": "Oral antihypertensives",
    "D": "Fluid restriction",
    "Answer": "A",
    "Comment": "The guidelines recommend immediate delivery and magnesium sulphate for eclampsia[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0041",
    "Questions": "What is the recommended treatment for syphilis in pregnancy?",
    "A": "Oral doxycycline",
    "B": "Oral azithromycin",
    "C": "Parenteral benzathine benzylpenicillin",
    "D": "Intravenous ceftriaxone",
    "Answer": "C",
    "Comment": "The guideline recommends benzathine benzylpenicillin as the treatment for syphilis in pregnancy[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0042",
    "Questions": "Which of the following is NOT a risk factor for preterm labour?",
    "A": "Multiple pregnancy",
    "B": "Previous preterm birth",
    "C": "Urinary tract infection",
    "D": "Being of a higher socio-economic status",
    "Answer": "D",
    "Comment": "The guidelines state that urinary tract infection is a risk factor for preterm labour, not socio-economic status[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0043",
    "Questions": "According to the guidelines what is the recommended management for preterm prelabour rupture of membranes (PPROM)?",
    "A": "Oral antibiotics and betamethasone",
    "B": "Oral antibiotics only",
    "C": "Betamethasone only",
    "D": "Immediate delivery",
    "Answer": "A",
    "Comment": "The guideline recommends oral antibiotics and betamethasone for preterm prelabour rupture of membranes[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0044",
    "Questions": "When should neonatal resuscitation be initiated?",
    "A": "Immediately after birth if the baby is not breathing",
    "B": "After 30 seconds of observation",
    "C": "After 1 minute of observation",
    "D": "Only if the Apgar score is low",
    "Answer": "A",
    "Comment": "The guideline states that neonatal resuscitation should be initiated immediately after birth if the baby is not breathing[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0045",
    "Questions": "What is the recommended management for postpartum haemorrhage (PPH)?",
    "A": "Oral ergometrine",
    "B": "Parenteral oxytocin",
    "C": "Uterine massage",
    "D": "Immediate surgical intervention",
    "Answer": "B",
    "Comment": "Parenteral oxytocin is the recommended management for postpartum haemorrhage[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0046",
    "Questions": "Which of the following is a recommended treatment for chronic pelvic pain?",
    "A": "NSAIDs",
    "B": "Oral antibiotics",
    "C": "Hormone therapy",
    "D": "Surgical intervention",
    "Answer": "A",
    "Comment": "The guideline recommends NSAIDs as a treatment for chronic pelvic pain[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0047",
    "Questions": "What is the recommended treatment for a patient with chronic kidney disease and a GFR < 30ml/min?",
    "A": "Referral to a nephrologist",
    "B": "Angiotensin-converting enzyme inhibitor (ACE-i)",
    "C": "Angiotensin II receptor blocker (ARB)",
    "D": "Loop diuretic",
    "Answer": "A",
    "Comment": "The guidelines recommend referral to a nephrologist for patients with CKD and a GFR < 30ml/min[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0048",
    "Questions": "Which of the following is a key management step for a patient with acute kidney injury at the PHC level?",
    "A": "Fluid restriction",
    "B": "Diuretics",
    "C": "Immediate referral",
    "D": "Potassium supplementation",
    "Answer": "C",
    "Comment": "The guidelines recommend immediate referral for patients with acute kidney injury[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0049",
    "Questions": "What is the recommended treatment for symptomatic Benign Prostatic Hyperplasia (BPH)?",
    "A": "Alpha-adrenergic blocker",
    "B": "Finasteride",
    "C": "Doxazosin",
    "D": "Tamsulosin",
    "Answer": "D",
    "Comment": "Tamsulosin is the recommended treatment for symptomatic Benign Prostatic Hyperplasia[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0050",
    "Questions": "What is the first-line treatment for a patient with Type 1 Diabetes Mellitus?",
    "A": "Oral metformin",
    "B": "Insulin",
    "C": "Oral glibenclamide",
    "D": "Lifestyle modifications",
    "Answer": "B",
    "Comment": "Insulin is the recommended first-line treatment for Type 1 Diabetes Mellitus[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0051",
    "Questions": "What is the recommended initial management for a patient with diabetic ketoacidosis (DKA)?",
    "A": "IV fluids",
    "B": "Insulin",
    "C": "Oral glucose",
    "D": "Subcutaneous insulin",
    "Answer": "A",
    "Comment": "IV fluids are the recommended initial management for diabetic ketoacidosis (DKA)[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0052",
    "Questions": "Which of the following is a key management step for a patient with diabetic foot ulcers?",
    "A": "Daily dressing changes",
    "B": "Oral antibiotics",
    "C": "Topical antiseptics",
    "D": "Referral to a specialist",
    "Answer": "D",
    "Comment": "The guideline states that patients with diabetic foot ulcers should be referred to a specialist[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0053",
    "Questions": "What is the recommended treatment for adult hypothyroidism?",
    "A": "Levothyroxine",
    "B": "Carbimazole",
    "C": "Propylthiouracil",
    "D": "Radioactive iodine",
    "Answer": "A",
    "Comment": "The guideline recommends levothyroxine as the treatment for adult hypothyroidism[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0054",
    "Questions": "What is the recommended management for a patient with a confirmed case of measles?",
    "A": "Acyclovir",
    "B": "Antibiotics",
    "C": "Symptomatic and supportive care",
    "D": "Referral to a specialist",
    "Answer": "C",
    "Comment": "The guideline states that symptomatic and supportive care is the recommended management for a patient with a confirmed case of measles[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0055",
    "Questions": "What is the recommended treatment for non-severe/uncomplicated malaria in a child weighing >5-15kg?",
    "A": "Artemether/lumefantrine 1 tablet",
    "B": "Artemether/lumefantrine 2 tablets",
    "C": "Artemether/lumefantrine 3 tablets",
    "D": "Artemether/lumefantrine 4 tablets",
    "Answer": "A",
    "Comment": "For a child weighing >5-15kg, the recommended dose of artemether/lumefantrine is 1 tablet[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0056",
    "Questions": "Which of the following is NOT a complication of malaria?",
    "A": "Hypoglycaemia",
    "B": "Severe anaemia",
    "C": "Jaundice",
    "D": "Hypertension",
    "Answer": "D",
    "Comment": "Hypertension is not listed as a complication of malaria, whereas hypoglycaemia, severe anaemia and jaundice are[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0057",
    "Questions": "What is the recommended prophylaxis for meningococcal meningitis in close contacts?",
    "A": "Ciprofloxacin",
    "B": "Ceftriaxone",
    "C": "Rifampicin",
    "D": "Azithromycin",
    "Answer": "C",
    "Comment": "The guideline recommends rifampicin as prophylaxis for meningococcal meningitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0058",
    "Questions": "What is the recommended management for a patient with suspected viral haemorrhagic fever (VHF)?",
    "A": "Immediate referral",
    "B": "Antibiotics",
    "C": "Antivirals",
    "D": "Supportive care",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral of a patient with suspected viral haemorrhagic fever[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0059",
    "Questions": "What is the recommended management for a patient with HIV and oral candidiasis?",
    "A": "Oral fluconazole",
    "B": "Nystatin oral suspension",
    "C": "Topical clotrimazole",
    "D": "Oral amphotericin B",
    "Answer": "A",
    "Comment": "The guideline recommends oral fluconazole as the treatment for oral candidiasis in a patient with HIV[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0060",
    "Questions": "What is the recommended treatment for a patient with HIV and chronic herpes simplex ulcers?",
    "A": "Oral aciclovir",
    "B": "Oral antibiotic",
    "C": "Topical antibiotic",
    "D": "Oral antifungal",
    "Answer": "A",
    "Comment": "The guideline recommends oral aciclovir for chronic herpes simplex ulcers in a patient with HIV[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0061",
    "Questions": "According to the guidelines what is the recommended management for a patient with HIV and cryptococcosis?",
    "A": "Immediate referral",
    "B": "Oral fluconazole",
    "C": "Oral amphotericin B",
    "D": "IV amphotericin B",
    "Answer": "A",
    "Comment": "The guideline states that a patient with HIV and cryptococcosis should be immediately referred[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0062",
    "Questions": "What is the recommended prophylaxis for HIV-exposed infants?",
    "A": "Zidovudine",
    "B": "Nevirapine",
    "C": "Cotrimoxazole",
    "D": "Lopinavir",
    "Answer": "B",
    "Comment": "The guidelines recommend nevirapine as prophylaxis for HIV-exposed infants[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0063",
    "Questions": "Which of the following is a side effect of ART in a patient with HIV?",
    "A": "Lactic acidosis",
    "B": "Hepatitis",
    "C": "Nephritis",
    "D": "Gout",
    "Answer": "A",
    "Comment": "The guideline lists lactic acidosis as a side effect of ART[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0064",
    "Questions": "What is the recommended treatment for a patient with vaginal discharge syndrome (VDS)?",
    "A": "Ciprofloxacin",
    "B": "Metronidazole and azithromycin",
    "C": "Doxycycline",
    "D": "Amoxicillin",
    "Answer": "B",
    "Comment": "The guideline states that the treatment for vaginal discharge syndrome is metronidazole and azithromycin[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0065",
    "Questions": "Which of the following is a recommended treatment for male urethritis syndrome (MUS)?",
    "A": "Metronidazole",
    "B": "Ceftriaxone and azithromycin",
    "C": "Ciprofloxacin",
    "D": "Oral doxycycline",
    "Answer": "B",
    "Comment": "The guideline recommends ceftriaxone and azithromycin for male urethritis syndrome[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0066",
    "Questions": "What is the recommended treatment for genital ulcer syndrome (GUS)?",
    "A": "Oral acyclovir",
    "B": "Oral doxycycline",
    "C": "Benzathine benzylpenicillin and oral doxycycline",
    "D": "Ceftriaxone and oral acyclovir",
    "Answer": "C",
    "Comment": "The guideline states that the treatment for genital ulcer syndrome is benzathine benzylpenicillin and oral doxycycline[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0067",
    "Questions": "According to the guidelines what is the correct treatment for genital warts?",
    "A": "Topical podophyllin",
    "B": "Surgical excision",
    "C": "Cryotherapy",
    "D": "Imiquimod cream",
    "Answer": "A",
    "Comment": "The guideline states that topical podophyllin is the recommended treatment for genital warts[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0068",
    "Questions": "At what age is the first dose of the BCG vaccine given?",
    "A": "At birth",
    "B": "6 weeks",
    "C": "10 weeks",
    "D": "14 weeks",
    "Answer": "A",
    "Comment": "The guidelines state that the BCG vaccine is administered at birth[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0069",
    "Questions": "At what age is the measles vaccine given?",
    "A": "At birth",
    "B": "6 months",
    "C": "9 months",
    "D": "12 months",
    "Answer": "C",
    "Comment": "The measles vaccine is administered at 9 months[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0070",
    "Questions": "What is the correct storage temperature for vaccines?",
    "A": "2-8??C",
    "B": "0-2??C",
    "C": "-2 to 0??C",
    "D": "-8 to -2??C",
    "Answer": "A",
    "Comment": "The guideline states that vaccines must be stored in a cold chain at 2-8??C[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0071",
    "Questions": "What is the recommended treatment for an acute arthritis attack caused by Gout?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Indomethacin",
    "D": "Ibuprofen",
    "Answer": "B",
    "Comment": "The guideline states that colchicine is the recommended treatment for acute gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0072",
    "Questions": "What is the recommended long-term treatment for chronic gout?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Indomethacin",
    "D": "Ibuprofen",
    "Answer": "A",
    "Comment": "The guideline states that allopurinol is the recommended long-term treatment for chronic gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0073",
    "Questions": "Which of the following is a recommended treatment for osteoarthrosis?",
    "A": "NSAIDs",
    "B": "Corticosteroids",
    "C": "Opioids",
    "D": "Referral for surgery",
    "Answer": "A",
    "Comment": "The guideline recommends NSAIDs for the treatment of osteoarthrosis[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0074",
    "Questions": "What is the recommended management for a patient with an acute stroke?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Thrombolysis",
    "D": "Anticoagulants",
    "Answer": "A",
    "Comment": "The guideline states that all patients with an acute stroke should be referred immediately[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0075",
    "Questions": "Which of the following is a recommended initial treatment for a patient in status epilepticus?",
    "A": "Oral diazepam",
    "B": "Intramuscular midazolam",
    "C": "IV lorazepam",
    "D": "IV phenytoin",
    "Answer": "B",
    "Comment": "The guideline recommends intramuscular midazolam as the initial treatment for status epilepticus[cite: 18].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0076",
    "Questions": "What is the recommended management for a child with febrile convulsions?",
    "A": "Antipyretic and referral",
    "B": "Anticonvulsant medication",
    "C": "Antipyretic and observation",
    "D": "IV diazepam",
    "Answer": "A",
    "Comment": "The guideline recommends an antipyretic for the fever and referral for the febrile convulsions in children[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0077",
    "Questions": "What is the recommended treatment for a patient with acute meningitis?",
    "A": "Oral antibiotics",
    "B": "IV antibiotics and immediate referral",
    "C": "IM antibiotics and observation",
    "D": "IV antibiotics and referral",
    "Answer": "B",
    "Comment": "The guideline states that a patient with acute meningitis should receive IV antibiotics and be referred immediately[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0078",
    "Questions": "Which of the following is the recommended treatment for a patient with acute psychosis?",
    "A": "Haloperidol",
    "B": "Diazepam",
    "C": "Lorazepam",
    "D": "Carbamazepine",
    "Answer": "A",
    "Comment": "The guideline recommends haloperidol for the treatment of acute psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0079",
    "Questions": "What is the recommended treatment for a patient with an overdose of an antidepressant?",
    "A": "Immediate referral",
    "B": "Activated charcoal",
    "C": "Gastric lavage",
    "D": "Supportive care",
    "Answer": "B",
    "Comment": "The guideline recommends activated charcoal for the treatment of an overdose of an antidepressant[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0080",
    "Questions": "What is the recommended management for a patient with chronic psychosis (schizophrenia)?",
    "A": "Oral antipsychotic medication",
    "B": "Hospitalization",
    "C": "ECT (Electroconvulsive Therapy)",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline recommends long-term use of oral antipsychotic medication for chronic psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0081",
    "Questions": "What is the recommended treatment for a patient with atopic eczema who has a superimposed bacterial infection?",
    "A": "Topical antibiotic",
    "B": "Oral amoxicillin",
    "C": "Topical fusidic acid",
    "D": "Oral cefalexin",
    "Answer": "D",
    "Comment": "The guideline recommends oral cefalexin for atopic eczema with a superimposed bacterial infection[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0082",
    "Questions": "According to the guidelines what is the recommended treatment for acute bacterial pneumonia in a child aged 3 years?",
    "A": "Amoxicillin",
    "B": "Azithromycin",
    "C": "Erythromycin",
    "D": "Ceftriaxone",
    "Answer": "A",
    "Comment": "The guidelines recommend amoxicillin for the treatment of acute bacterial pneumonia in children aged 3 years[cite: 17].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0083",
    "Questions": "What is the recommended management for a patient with a confirmed diagnosis of Bell's Palsy?",
    "A": "Oral corticosteroids",
    "B": "Oral antiviral medication",
    "C": "Oral antibiotic",
    "D": "Oral pain medication",
    "Answer": "A",
    "Comment": "The guideline recommends oral corticosteroids for Bell's Palsy[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0084",
    "Questions": "Which of the following is a recommended treatment for a patient with scabies?",
    "A": "Permethrin 5% cream",
    "B": "Calamine lotion",
    "C": "Benzyl benzoate 25% lotion",
    "D": "Oral ivermectin",
    "Answer": "C",
    "Comment": "The guideline recommends benzyl benzoate 25% lotion as a treatment for scabies[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0085",
    "Questions": "What is the recommended treatment for a patient with chronic hypertension who has developed a cough on an ACE-inhibitor?",
    "A": "Switch to a beta-blocker",
    "B": "Switch to a thiazide diuretic",
    "C": "Switch to an Angiotensin II Receptor Blocker (ARB)",
    "D": "Add a calcium channel blocker",
    "Answer": "C",
    "Comment": "The guideline states that if a patient on an ACE-inhibitor develops a cough, they should be switched to an ARB[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0086",
    "Questions": "What is the recommended management for a patient with a hypertensive emergency?",
    "A": "Oral nifedipine",
    "B": "Oral hydralazine",
    "C": "IV labetalol",
    "D": "Immediate referral",
    "Answer": "D",
    "Comment": "The guideline states that a patient with a hypertensive emergency should be referred immediately[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0087",
    "Questions": "What is the recommended treatment for an adult with stable angina?",
    "A": "Aspirin",
    "B": "Sublingual nitroglycerin",
    "C": "Oral beta-blocker",
    "D": "Oral calcium channel blocker",
    "Answer": "B",
    "Comment": "The guideline recommends sublingual nitroglycerin as the treatment for an adult with stable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0088",
    "Questions": "What is the recommended treatment for a patient with an unstable angina?",
    "A": "Immediate referral",
    "B": "Oral nitroglycerin",
    "C": "Sublingual nitroglycerin",
    "D": "Aspirin",
    "Answer": "D",
    "Comment": "The guideline recommends aspirin as a treatment for unstable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0089",
    "Questions": "Which of the following is the correct management for a patient with cardiac arrest?",
    "A": "Immediate referral",
    "B": "Cardio-pulmonary resuscitation (CPR)",
    "C": "Intravenous adrenaline",
    "D": "Oral aspirin",
    "Answer": "B",
    "Comment": "The guideline states that the correct management for cardiac arrest is cardio-pulmonary resuscitation (CPR)[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0090",
    "Questions": "What is the recommended treatment for a patient with mild congestive cardiac failure?",
    "A": "ACE-inhibitor and diuretic",
    "B": "ACE-inhibitor and beta-blocker",
    "C": "Digoxin",
    "D": "Diuretic",
    "Answer": "A",
    "Comment": "The guideline recommends ACE-inhibitor and diuretic as the treatment for mild congestive cardiac failure[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0091",
    "Questions": "What is the recommended treatment for acute pulmonary oedema?",
    "A": "IV furosemide",
    "B": "Oral furosemide",
    "C": "IV morphine",
    "D": "IV nitroglycerin",
    "Answer": "A",
    "Comment": "The guideline recommends IV furosemide for the treatment of acute pulmonary oedema[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0092",
    "Questions": "Which of the following is the recommended treatment for a child with rheumatic fever?",
    "A": "Oral amoxicillin",
    "B": "Oral erythromycin",
    "C": "Parenteral benzathine benzylpenicillin",
    "D": "Oral penicillin V",
    "Answer": "C",
    "Comment": "The guideline recommends parenteral benzathine benzylpenicillin as the treatment for a child with rheumatic fever[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0093",
    "Questions": "Which is a recommended treatment for dental caries?",
    "A": "Oral antibiotics",
    "B": "Topical fluoride varnish",
    "C": "Oral analgesics",
    "D": "Referral to a dentist",
    "Answer": "B",
    "Comment": "Topical fluoride varnish is a recommended treatment for dental caries[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0094",
    "Questions": "What is the recommended management for a patient with chronic diarrhoea?",
    "A": "Loperamide",
    "B": "Oral antibiotics",
    "C": "Referral for investigation",
    "D": "Oral rehydration solution (ORS)",
    "Answer": "C",
    "Comment": "The guideline states that chronic diarrhoea requires investigation and referral to determine the underlying cause[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0095",
    "Questions": "Which of the following is a key management step for a patient with complicated severe acute malnutrition (SAM)?",
    "A": "Outpatient care with RUTF",
    "B": "Inpatient care with F75",
    "C": "Oral antibiotics",
    "D": "Zinc sulphate",
    "Answer": "B",
    "Comment": "The guideline states that complicated SAM requires inpatient care, starting with F75[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0096",
    "Questions": "What is the recommended treatment for an adult with type 2 diabetes and hypertension?",
    "A": "Metformin",
    "B": "Glibenclamide",
    "C": "ACE-inhibitor",
    "D": "Insulin",
    "Answer": "C",
    "Comment": "The guideline recommends an ACE-inhibitor for a patient with type 2 diabetes and hypertension[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0097",
    "Questions": "What is the recommended treatment for an adult with type 2 diabetes and no comorbidities?",
    "A": "Metformin",
    "B": "Glibenclamide",
    "C": "Insulin",
    "D": "ACE-inhibitor",
    "Answer": "A",
    "Comment": "The guideline recommends metformin as the first-line treatment for type 2 diabetes in adults with no comorbidities[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0098",
    "Questions": "What is the recommended treatment for a patient with a viral haemorrhagic fever?",
    "A": "Supportive care",
    "B": "Oral antibiotics",
    "C": "Oral antivirals",
    "D": "IV fluids",
    "Answer": "A",
    "Comment": "The guideline states that the management for a viral haemorrhagic fever is supportive care[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0099",
    "Questions": "What is the recommended treatment for a patient with candidiasis of the skin?",
    "A": "Topical antifungal cream",
    "B": "Oral fluconazole",
    "C": "Oral nystatin",
    "D": "Oral ketoconazole",
    "Answer": "A",
    "Comment": "The guideline recommends topical antifungal cream for candidiasis of the skin[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0100",
    "Questions": "Which of the following is a recommended treatment for an adult with a perianal abscess?",
    "A": "Oral antibiotic",
    "B": "Incision and drainage",
    "C": "Topical antibiotic",
    "D": "Analgesics",
    "Answer": "B",
    "Comment": "The guideline states that incision and drainage is the recommended management for a perianal abscess[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0101",
    "Questions": "Which of the following is a recommended treatment for an adult with constipation?",
    "A": "Bulk-forming laxatives",
    "B": "Loperamide",
    "C": "Magnesium hydroxide",
    "D": "Bisacodyl",
    "Answer": "A",
    "Comment": "The guideline recommends bulk-forming laxatives for constipation in adults[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0102",
    "Questions": "What is the recommended treatment for a child with chronic constipation?",
    "A": "Lactulose",
    "B": "Oral paraffin",
    "C": "Bisacodyl",
    "D": "Loperamide",
    "Answer": "A",
    "Comment": "The guideline recommends lactulose for a child with chronic constipation[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0103",
    "Questions": "What is the recommended management for a patient with a suspected anal fissure?",
    "A": "Surgical referral",
    "B": "Topical corticosteroids",
    "C": "Bulk-forming laxatives",
    "D": "Antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends bulk-forming laxatives for a patient with a suspected anal fissure[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0104",
    "Questions": "What is the recommended treatment for an adult with acute uncomplicated diarrhoea?",
    "A": "Oral antibiotics",
    "B": "Oral rehydration solution",
    "C": "Loperamide",
    "D": "Oral probiotics",
    "Answer": "B",
    "Comment": "The guideline recommends oral rehydration solution for acute uncomplicated diarrhoea[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0105",
    "Questions": "What is the recommended treatment for a child with acute diarrhoea?",
    "A": "Oral antibiotics",
    "B": "Oral rehydration solution",
    "C": "Zinc supplementation",
    "D": "Loperamide",
    "Answer": "B",
    "Comment": "The guideline recommends oral rehydration solution for a child with acute diarrhoea[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0106",
    "Questions": "Which of the following is a recommended treatment for a patient with dysentery?",
    "A": "Oral ciprofloxacin",
    "B": "Oral azithromycin",
    "C": "Oral metronidazole",
    "D": "Oral amoxicillin",
    "Answer": "B",
    "Comment": "The guideline recommends oral azithromycin for dysentery[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0107",
    "Questions": "What is the recommended treatment for a patient with uncomplicated tinea pedis (athlete's foot)?",
    "A": "Oral griseofulvin",
    "B": "Topical antifungal cream",
    "C": "Topical antiseptic",
    "D": "Oral antibiotic",
    "Answer": "B",
    "Comment": "The guideline recommends a topical antifungal cream for uncomplicated tinea pedis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0108",
    "Questions": "What is the recommended treatment for a patient with tinea capitis (scalp ringworm)?",
    "A": "Topical antifungal cream",
    "B": "Oral griseofulvin",
    "C": "Oral fluconazole",
    "D": "Oral ketoconazole",
    "Answer": "B",
    "Comment": "The guideline recommends oral griseofulvin for tinea capitis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0109",
    "Questions": "What is the recommended management for a patient with a chronic lower leg ulcer?",
    "A": "Oral amoxicillin",
    "B": "Oral cefalexin",
    "C": "Topical antibiotic",
    "D": "Topical steroid",
    "Answer": "B",
    "Comment": "The guideline recommends oral cefalexin for a chronic lower leg ulcer[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0110",
    "Questions": "What is the recommended management for a patient with a boil?",
    "A": "Incision and drainage",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Oral painkillers",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a boil is incision and drainage[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0111",
    "Questions": "Which of the following is a recommended treatment for an adult with a sore throat?",
    "A": "Oral antibiotics",
    "B": "Oral analgesics",
    "C": "Referral to a specialist",
    "D": "Topical anaesthetic",
    "Answer": "B",
    "Comment": "The guideline recommends oral analgesics for a sore throat[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0112",
    "Questions": "What is the recommended management for a patient with a suspected deep vein thrombosis (DVT)?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Bed rest",
    "D": "Elastic stockings",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected DVT[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0113",
    "Questions": "What is the recommended treatment for a patient with a nosebleed?",
    "A": "Pinching the nostrils and leaning forward",
    "B": "Pinching the nostrils and leaning backward",
    "C": "Packing the nose with cotton",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a nosebleed is to pinch the nostrils and lean forward[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0114",
    "Questions": "What is the recommended management for a patient with a suspected fracture?",
    "A": "Surgical referral",
    "B": "Immobilization and referral",
    "C": "Oral painkillers",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0115",
    "Questions": "Which of the following is a recommended treatment for a patient with a sprained ankle?",
    "A": "elevation (RICE)",
    "B": "Immobilization",
    "C": "Surgical referral",
    "D": "Oral antibiotics",
    "Answer": "A",
    "Comment": "The guideline recommends Rest, Ice, Compression, Elevation (RICE) for a sprained ankle[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0116",
    "Questions": "What is the recommended treatment for a patient with a foreign body in the eye?",
    "A": "Flushing the eye with water",
    "B": "Removal of the foreign body with a cotton swab",
    "C": "Referral to an ophthalmologist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to an ophthalmologist for a foreign body in the eye[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0117",
    "Questions": "What is the recommended management for a patient with a suspected retinal detachment?",
    "A": "Immediate referral to an ophthalmologist",
    "B": "Oral painkiller",
    "C": "Bed rest",
    "D": "Referral to a general practitioner",
    "Answer": "A",
    "Comment": "The guideline states that a patient with a suspected retinal detachment should be referred to an ophthalmologist immediately[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0118",
    "Questions": "What is the recommended management for a patient with acute otitis media?",
    "A": "Oral antibiotics",
    "B": "Referral to a specialist",
    "C": "Oral analgesics",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends oral analgesics for the management of acute otitis media[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0119",
    "Questions": "What is the recommended management for a patient with chronic otitis media?",
    "A": "Oral antibiotics",
    "B": "Topical antibiotics",
    "C": "Referral to a specialist",
    "D": "Oral painkiller",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a patient with chronic otitis media[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0120",
    "Questions": "What is the recommended management for a patient with a suspected mastoiditis?",
    "A": "Immediate referral",
    "B": "Oral antibiotics",
    "C": "Intravenous antibiotics",
    "D": "Surgical referral",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected mastoiditis[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0121",
    "Questions": "What is the recommended treatment for a patient with suspected appendicitis?",
    "A": "Oral antibiotics",
    "B": "Analgesics",
    "C": "Immediate referral for surgery",
    "D": "Observation and pain management",
    "Answer": "C",
    "Comment": "The guideline recommends immediate referral for surgery for a patient with suspected appendicitis[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0122",
    "Questions": "Which is a recommended treatment for a patient with oral candidiasis?",
    "A": "Oral nystatin",
    "B": "Oral fluconazole",
    "C": "Topical antifungal cream",
    "D": "Oral itraconazole",
    "Answer": "A",
    "Comment": "The guideline recommends oral nystatin for the treatment of oral candidiasis[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0123",
    "Questions": "What is the recommended treatment for a patient with a dental abscess?",
    "A": "Oral antibiotics",
    "B": "Incision and drainage",
    "C": "Referral to a dentist",
    "D": "Oral pain medication",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a dentist for a dental abscess[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0124",
    "Questions": "What is the recommended treatment for a patient with a suspected cellulitis?",
    "A": "Oral antibiotics",
    "B": "Topical antibiotics",
    "C": "Topical steroids",
    "D": "Incision and drainage",
    "Answer": "A",
    "Comment": "The guideline recommends oral antibiotics for the treatment of a suspected cellulitis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0125",
    "Questions": "Which of the following is a recommended management step for a patient with impetigo?",
    "A": "Topical antibiotic",
    "B": "Oral antibiotic",
    "C": "Topical steroid",
    "D": "Incision and drainage",
    "Answer": "A",
    "Comment": "The guideline recommends a topical antibiotic for the treatment of impetigo[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0126",
    "Questions": "What is the recommended management for a patient with tinea corporis?",
    "A": "Oral antifungal",
    "B": "Topical antifungal",
    "C": "Oral antibiotic",
    "D": "Topical steroid",
    "Answer": "B",
    "Comment": "The guideline recommends a topical antifungal for the treatment of tinea corporis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0127",
    "Questions": "Which of the following is the recommended treatment for a patient with a boil?",
    "A": "Incision and drainage",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Oral painkillers",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a boil is incision and drainage[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0128",
    "Questions": "What is the recommended management for a patient with a minor burn?",
    "A": "Topical antiseptic",
    "B": "Surgical debridement",
    "C": "Referral to a specialist",
    "D": "Cooling with water",
    "Answer": "D",
    "Comment": "The guideline recommends cooling a minor burn with water[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0129",
    "Questions": "What is the recommended management for a patient with a major burn?",
    "A": "Oral antibiotics",
    "B": "Immediate referral",
    "C": "Topical antibiotics",
    "D": "Pain medication",
    "Answer": "B",
    "Comment": "The guideline recommends immediate referral for a patient with a major burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0130",
    "Questions": "What is the recommended management for a patient with a suspected chemical burn?",
    "A": "Neutralizing the chemical with an alkali",
    "B": "Neutralizing the chemical with an acid",
    "C": "Irrigation with water",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends irrigation with water for a chemical burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0131",
    "Questions": "What is the recommended management for a patient with an electrical burn?",
    "A": "Immediate referral",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Pain medication",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with an electrical burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0132",
    "Questions": "What is the recommended management for a patient with a suspected stroke?",
    "A": "Oral aspirin",
    "B": "IV thrombolysis",
    "C": "Immediate referral",
    "D": "Physical therapy",
    "Answer": "C",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected stroke[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0133",
    "Questions": "Which of the following is the correct management for a patient with chronic psychosis?",
    "A": "Oral antipsychotic medication",
    "B": "Hospitalization",
    "C": "ECT (Electroconvulsive Therapy)",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline recommends long-term oral antipsychotic medication for chronic psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0134",
    "Questions": "What is the recommended treatment for a patient with a suspected overdose of a benzodiazepine?",
    "A": "Flumazenil",
    "B": "Activated charcoal",
    "C": "Supportive care",
    "D": "Referral for psychiatric evaluation",
    "Answer": "A",
    "Comment": "The guideline recommends flumazenil for a benzodiazepine overdose[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0135",
    "Questions": "What is the recommended management for a patient with a foreign body in the ear?",
    "A": "Removal of the foreign body",
    "B": "Irrigation",
    "C": "Referral to a specialist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a foreign body in the ear[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0136",
    "Questions": "What is the recommended management for a patient with a foreign body in the nose?",
    "A": "Removal of the foreign body",
    "B": "Irrigation",
    "C": "Referral to a specialist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a foreign body in the nose[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0137",
    "Questions": "What is the recommended management for a patient with a suspected head injury?",
    "A": "Immediate referral",
    "B": "Oral pain medication",
    "C": "Observation",
    "D": "CT scan",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected head injury[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0138",
    "Questions": "What is the recommended management for a patient with a suspected spinal injury?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Oral pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected spinal injury[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0139",
    "Questions": "What is the recommended management for a patient with a suspected hip fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected hip fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0140",
    "Questions": "What is the recommended management for a patient with a suspected femoral neck fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected femoral neck fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0141",
    "Questions": "What is the recommended management for a patient with a suspected humeral shaft fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected humeral shaft fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0142",
    "Questions": "What is the recommended management for a patient with a suspected radius fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected radius fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0143",
    "Questions": "What is the recommended management for a patient with a suspected carpal tunnel syndrome?",
    "A": "Referral to a physiotherapist",
    "B": "Oral pain medication",
    "C": "Splinting",
    "D": "Surgical referral",
    "Answer": "C",
    "Comment": "The guideline recommends splinting for carpal tunnel syndrome[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0144",
    "Questions": "What is the recommended treatment for a patient with a suspected deep vein thrombosis (DVT)?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Bed rest",
    "D": "Elastic stockings",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected DVT[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0145",
    "Questions": "What is the recommended management for a patient with a suspected pulmonary embolism?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Oxygen therapy",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected pulmonary embolism[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0146",
    "Questions": "What is the recommended management for a patient with a suspected acute myocardial infarction (AMI)?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Nitroglycerin",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected AMI[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0147",
    "Questions": "What is the recommended management for a patient with a suspected unstable angina?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Nitroglycerin",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected unstable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0148",
    "Questions": "What is the recommended management for a patient with a suspected acute cardiac failure?",
    "A": "Immediate referral",
    "B": "Diuretics",
    "C": "ACE-inhibitor",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute cardiac failure[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0149",
    "Questions": "What is the recommended management for a patient with a suspected acute pulmonary oedema?",
    "A": "Immediate referral",
    "B": "Diuretics",
    "C": "IV furosemide",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute pulmonary oedema[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0150",
    "Questions": "What is the recommended management for a patient with a suspected acute hypertensive crisis?",
    "A": "Immediate referral",
    "B": "Oral nifedipine",
    "C": "IV labetalol",
    "D": "Oral hydralazine",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute hypertensive crisis[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0151",
    "Questions": "What is the recommended management for a patient with a suspected acute stroke?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Thrombolysis",
    "D": "Anticoagulants",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected stroke[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0152",
    "Questions": "What is the recommended management for a patient with a suspected acute meningitis?",
    "A": "Immediate referral",
    "B": "IV antibiotics",
    "C": "Oral antibiotics",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute meningitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0153",
    "Questions": "What is the recommended management for a patient with a suspected encephalitis?",
    "A": "Immediate referral",
    "B": "IV antivirals",
    "C": "Oral antivirals",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected encephalitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0154",
    "Questions": "What is the recommended management for a patient with a suspected tetanus?",
    "A": "Immediate referral",
    "B": "Tetanus immunoglobulin",
    "C": "Oral antibiotics",
    "D": "Referral to a general practitioner",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected tetanus[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0155",
    "Questions": "What is the recommended management for a patient with a suspected rabies?",
    "A": "Immediate referral",
    "B": "Rabies vaccine",
    "C": "Rabies immunoglobulin",
    "D": "Oral antibiotics",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected rabies[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0156",
    "Questions": "What is the recommended management for a patient with a suspected snakebite?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected snakebite[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0157",
    "Questions": "What is the recommended management for a patient with a suspected spider bite?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected spider bite[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0158",
    "Questions": "What is the recommended management for a patient with a suspected scorpion sting?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected scorpion sting[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0159",
    "Questions": "What is the recommended management for a patient with a suspected drug overdose?",
    "A": "Immediate referral",
    "B": "Activated charcoal",
    "C": "Gastric lavage",
    "D": "Supportive care",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected drug overdose[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0160",
    "Questions": "What is the recommended management for a patient with a suspected suicidal attempt?",
    "A": "Immediate referral for psychiatric evaluation",
    "B": "Observation",
    "C": "Pain medication",
    "D": "Discharge home",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for psychiatric evaluation for a patient with a suspected suicidal attempt[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "Maternity0161",
    "Questions": "Which of the following is a key principle of respectful maternity care?",
    "A": "Always conduct examinations in public for transparency",
    "B": "Ensure informed consent and maintain confidentiality",
    "C": "Do not allow birth companions in labour wards",
    "D": "Share patient details with non-medical staff for safety",
    "Answer": "B",
    "Comment": "Respectful maternity care requires informed consent, privacy, and confidentiality to uphold women's dignity.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0162",
    "Questions": "According to the guidelines what proportion of women in South Africa experience intimate partner violence during or after pregnancy?",
    "A": "1 in 10",
    "B": "1 in 6",
    "C": "1 in 4",
    "D": "1 in 2",
    "Answer": "C",
    "Comment": "This is the figure quoted in the guideline",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0163",
    "Questions": "What is the first-line pharmacological treatment for moderate to severe perinatal depression or anxiety?",
    "A": "Tricyclic antidepressants",
    "B": "SSRIs",
    "C": "Benzodiazepines",
    "D": "Lithium",
    "Answer": "B",
    "Comment": "SSRIs are safe and effective as first-line treatment during pregnancy and breastfeeding.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0164",
    "Questions": "How is primary postpartum haemorrhage (PPH) defined?",
    "A": "Excessive bleeding within 12 hours post-delivery",
    "B": "Excessive bleeding from the genital tract within 24 hours",
    "C": "Blood loss greater than 1000ml within 48 hours",
    "D": "Blood loss greater than 2500ml at any point post-delivery",
    "Answer": "B",
    "Comment": "Primary PPH is defined as excessive bleeding within 24 hours after delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0165",
    "Questions": "Which of the following is a recognised risk factor for maternal mental health conditions?",
    "A": "High educational attainment",
    "B": "Refugee or asylum seeker status",
    "C": "Multiparity without complications",
    "D": "Access to social support networks",
    "Answer": "B",
    "Comment": "Being a refugee or asylum seeker is a recognised risk factor.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0166",
    "Questions": "What is the purpose of the BANC Plus antenatal schedule?",
    "A": "To reduce number of antenatal visits",
    "B": "To increase visits for improved monitoring",
    "C": "To replace ultrasound scans",
    "D": "To avoid routine laboratory tests",
    "Answer": "B",
    "Comment": "BANC Plus increased the number of visits to improve outcomes.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0167",
    "Questions": "Which of the following is NOT a type of disrespect and abuse in maternity care?",
    "A": "Failure to provide services due to prejudice",
    "B": "Denying mobility or food in labour",
    "C": "Encouraging chosen birth position",
    "D": "Unwanted physical contact",
    "Answer": "C",
    "Comment": "Encouraging chosen birth positions is part of respectful care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0168",
    "Questions": "Which simple measure can improve respectful communication during labour?",
    "A": "Shouting instructions",
    "B": "Using patient???s preferred name",
    "C": "Withholding information until delivery",
    "D": "Allowing only one examination per labour",
    "Answer": "B",
    "Comment": "Calling women by their preferred name improves rapport and respect.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0169",
    "Questions": "Which statement about adolescent pregnancy is correct?",
    "A": "It carries lower risk than adult pregnancy",
    "B": "It is associated with higher risk of eclampsia and infections",
    "C": "It is always intended",
    "D": "It results in better neonatal outcomes",
    "Answer": "B",
    "Comment": "Adolescents face higher risks of complications such as eclampsia and infection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0170",
    "Questions": "Which of the following should be done when a woman is experiencing pregnancy loss?",
    "A": "Leave her alone without explanation",
    "B": "Explain causes if known using simple language",
    "C": "Deny her access to the baby",
    "D": "Transfer her immediately without support",
    "Answer": "B",
    "Comment": "Women should receive explanations and compassionate support during loss.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0171",
    "Questions": "Which test is routinely used to screen for syphilis in pregnancy?",
    "A": "GeneXpert",
    "B": "RPR",
    "C": "CTG",
    "D": "HIV PCR",
    "Answer": "B",
    "Comment": "RPR is the standard screening test for syphilis in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0172",
    "Questions": "What is the recommended first-line uterotonic for prevention of postpartum haemorrhage?",
    "A": "Carboprost",
    "B": "Oxytocin",
    "C": "Misoprostol",
    "D": "Ergometrine",
    "Answer": "B",
    "Comment": "Oxytocin is the drug of choice for prevention of PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0173",
    "Questions": "Which of the following defines pre-eclampsia with severe features?",
    "A": "Proteinuria only",
    "B": "BP ??�160/110 with organ dysfunction",
    "C": "BP ??�140/90 after 20 weeks with no symptoms",
    "D": "Any rise in BP in first trimester",
    "Answer": "B",
    "Comment": "Severe features include high BP with organ dysfunction such as headache, visual changes, or elevated creatinine.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0174",
    "Questions": "What is the management of a septic miscarriage?",
    "A": "Observation only",
    "B": "Immediate uterine evacuation and IV antibiotics",
    "C": "Oral antibiotics at home",
    "D": "Iron supplementation only",
    "Answer": "B",
    "Comment": "Septic miscarriage requires immediate uterine evacuation and IV antibiotics.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0175",
    "Questions": "Which fetal heart rate is considered normal during labour?",
    "A": "80???100 bpm",
    "B": "100???110 bpm",
    "C": "110???160 bpm",
    "D": "160???200 bpm",
    "Answer": "C",
    "Comment": "Normal fetal heart rate in labour is 110???160 bpm.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0176",
    "Questions": "What is the safest delivery method for a transverse lie at term?",
    "A": "Normal vaginal delivery",
    "B": "Forceps extraction",
    "C": "Caesarean section",
    "D": "Vacuum delivery",
    "Answer": "C",
    "Comment": "Transverse lie usually requires caesarean section for safe delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0177",
    "Questions": "What is the most appropriate response if a client is aggressive during labour care?",
    "A": "Argue and assert authority",
    "B": "Remain calm and acknowledge their emotions",
    "C": "Ignore the client",
    "D": "Remove their birth companion",
    "Answer": "B",
    "Comment": "Remaining calm and acknowledging emotion de-escalates situations.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0178",
    "Questions": "Which of the following is a recommended food supplement during pregnancy in South Africa?",
    "A": "Vitamin C",
    "B": "Folic acid and iron",
    "C": "High-dose Vitamin A",
    "D": "Calcium only",
    "Answer": "B",
    "Comment": "Folic acid and iron supplementation is standard in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0179",
    "Questions": "Which statement about kangaroo care is correct?",
    "A": "It should be avoided in preterm babies",
    "B": "It is recommended after delivery for bonding and warmth",
    "C": "It replaces breastfeeding",
    "D": "It is unsafe after caesarean delivery",
    "Answer": "B",
    "Comment": "Skin-to-skin contact improves bonding and thermoregulation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0180",
    "Questions": "What is the most important first step in managing antepartum haemorrhage?",
    "A": "Immediate caesarean section",
    "B": "Determine maternal stability and resuscitate",
    "C": "Start oxytocin infusion immediately",
    "D": "Discharge home with bed rest",
    "Answer": "B",
    "Comment": "Initial step is resuscitation and maternal stabilisation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0181",
    "Questions": "Which infection is specifically screened for at booking in antenatal care?",
    "A": "Hepatitis C",
    "B": "Malaria",
    "C": "HIV and syphilis",
    "D": "Dengue",
    "Answer": "C",
    "Comment": "HIV and syphilis are part of routine antenatal screening.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0182",
    "Questions": "Which of the following is NOT a feature of respectful workplace culture?",
    "A": "Positive feedback and support",
    "B": "Public criticism of colleagues",
    "C": "Constructive mentoring",
    "D": "Confidential performance feedback",
    "Answer": "B",
    "Comment": "Public criticism undermines respect and morale.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0183",
    "Questions": "What is the role of a birth companion during labour?",
    "A": "Provide emotional and practical support",
    "B": "Administer medications",
    "C": "Perform vaginal examinations",
    "D": "Direct medical management",
    "Answer": "A",
    "Comment": "Birth companions provide non-clinical emotional and practical support.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0184",
    "Questions": "What is the most common mental health condition affecting South African women during or after pregnancy?",
    "A": "Schizophrenia",
    "B": "Perinatal depression and anxiety",
    "C": "Bipolar disorder",
    "D": "PTSD",
    "Answer": "B",
    "Comment": "About 1 in 3 women experience perinatal depression or anxiety.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0185",
    "Questions": "Which of the following is a recommended screening schedule for maternal mental health?",
    "A": "Only postpartum",
    "B": "Once at booking and ideally each trimester",
    "C": "Only if patient has prior psychiatric history",
    "D": "Only in adolescents",
    "Answer": "B",
    "Comment": "Screening at booking and each trimester if possible helps early detection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0186",
    "Questions": "Which of the following describes Baby Blues?",
    "A": "Persistent depression beyond 6 months",
    "B": "Temporary emotional changes resolving within 2 weeks",
    "C": "Severe psychosis needing admission",
    "D": "Anxiety disorder requiring benzodiazepines",
    "Answer": "B",
    "Comment": "Baby blues are transient emotional changes usually resolving within 2 weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0187",
    "Questions": "What is the recommended first-line treatment for eclampsia?",
    "A": "Diazepam",
    "B": "Morphine",
    "C": "Magnesium sulphate",
    "D": "Phenytoin",
    "Answer": "C",
    "Comment": "Magnesium sulphate is the drug of choice for preventing and treating seizures in eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0188",
    "Questions": "Which sign is most suggestive of abruptio placentae rather than placenta praevia?",
    "A": "Painless vaginal bleeding",
    "B": "Painful bleeding with uterine tenderness",
    "C": "Fetal parts easily felt",
    "D": "Absence of uterine contractions",
    "Answer": "B",
    "Comment": "Abruptio placentae typically presents with painful bleeding and uterine tenderness.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0189",
    "Questions": "What is the safest method of induction of labour in a woman with a previous caesarean section?",
    "A": "High-dose oxytocin",
    "B": "Prostaglandin E2 gel",
    "C": "Mechanical methods such as Foley catheter",
    "D": "Oral misoprostol",
    "Answer": "C",
    "Comment": "Mechanical induction methods are safer in women with prior uterine scar.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0190",
    "Questions": "Which of the following is part of the active management of the third stage of labour?",
    "A": "Allowing placenta to deliver spontaneously",
    "B": "Administering oxytocin",
    "C": "Encouraging supine position only",
    "D": "Delaying cord clamping for 10 minutes",
    "Answer": "B",
    "Comment": "Active management includes oxytocin administration to reduce risk of PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0191",
    "Questions": "What is the most appropriate management for shoulder dystocia?",
    "A": "Apply fundal pressure",
    "B": "McRoberts manoeuvre and suprapubic pressure",
    "C": "Delay interventions until contractions resume",
    "D": "Vacuum extraction immediately",
    "Answer": "B",
    "Comment": "First-line management includes McRoberts manoeuvre and suprapubic pressure.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0192",
    "Questions": "Which of the following is a key danger sign in postpartum women?",
    "A": "Mild lochia",
    "B": "Transient night sweats",
    "C": "Heavy vaginal bleeding",
    "D": "Fatigue only",
    "Answer": "C",
    "Comment": "Heavy vaginal bleeding is a key danger sign for PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0193",
    "Questions": "What is the management of a retained placenta after vaginal delivery?",
    "A": "Observe for 24 hours",
    "B": "Uterine massage only",
    "C": "Manual removal under anaesthesia",
    "D": "Give oral antibiotics and discharge",
    "Answer": "C",
    "Comment": "Manual removal under anaesthesia is needed if placenta does not deliver.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0194",
    "Questions": "Which antiretroviral regimen is most commonly recommended for pregnant women living with HIV in South Africa?",
    "A": "AZT monotherapy",
    "B": "TLD regimen (Tenofovir, Lamivudine, Dolutegravir)",
    "C": "Efavirenz monotherapy",
    "D": "Protease inhibitors only",
    "Answer": "C",
    "Comment": "TLD is the current first line regimen",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0195",
    "Questions": "Which measure helps prevent neural tube defects?",
    "A": "Vitamin C",
    "B": "Folic acid supplementation",
    "C": "Iron only",
    "D": "Vitamin D",
    "Answer": "B",
    "Comment": "Folic acid supplementation before and during pregnancy reduces neural tube defects.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0196",
    "Questions": "Which of the following defines gestational diabetes?",
    "A": "Diabetes diagnosed before pregnancy",
    "B": "Hyperglycaemia first recognised in pregnancy",
    "C": "Type 1 diabetes in pregnancy",
    "D": "Any elevated glucose after delivery",
    "Answer": "B",
    "Comment": "Gestational diabetes is hyperglycaemia first recognised during pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0197",
    "Questions": "Which of the following maternal conditions increases risk of pre-eclampsia?",
    "A": "Multiparity",
    "B": "Obesity and chronic hypertension",
    "C": "Short stature only",
    "D": "History of appendicitis",
    "Answer": "B",
    "Comment": "Obesity and chronic hypertension are risk factors for pre-eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0198",
    "Questions": "What is the definition of preterm labour?",
    "A": "Labour before 28 weeks",
    "B": "Labour before 37 completed weeks",
    "C": "Labour before 20 weeks",
    "D": "Labour before 34 completed weeks",
    "Answer": "B",
    "Comment": "Preterm labour refers to labour occurring before 37 completed weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0199",
    "Questions": "Which statement about VBAC (Vaginal Birth After Caesarean) is correct?",
    "A": "It is contraindicated in all women",
    "B": "It is possible in selected women with one previous low transverse scar",
    "C": "It is safest after three caesareans",
    "D": "It should be avoided in rural hospitals",
    "Answer": "B",
    "Comment": "VBAC can be safely attempted in selected women with one prior low transverse caesarean.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0200",
    "Questions": "What is the first step in neonatal resuscitation?",
    "A": "Administer oxygen",
    "B": "Check breathing and stimulate the baby",
    "C": "Give chest compressions immediately",
    "D": "Insert IV fluids",
    "Answer": "B",
    "Comment": "Initial neonatal resuscitation begins with checking breathing and stimulation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0201",
    "Questions": "Which of the following contraceptive methods is safe in breastfeeding women from 6 weeks postpartum?",
    "A": "Combined oral contraceptives",
    "B": "Progestogen-only methods",
    "C": "Estrogen patch",
    "D": "Emergency contraception only",
    "Answer": "B",
    "Comment": "Progestogen-only methods are safe for breastfeeding mothers from 6 weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0202",
    "Questions": "Which infection in pregnancy requires intrapartum penicillin prophylaxis?",
    "A": "HIV",
    "B": "Group B Streptococcus",
    "C": "Malaria",
    "D": "Hepatitis B",
    "Answer": "B",
    "Comment": "Intrapartum penicillin prophylaxis is used for Group B Streptococcus.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0203",
    "Questions": "Which fetal presentation usually requires caesarean delivery?",
    "A": "Occiput anterior",
    "B": "Breech",
    "C": "Transverse lie",
    "D": "Face presentation",
    "Answer": "C",
    "Comment": "Transverse lie usually requires caesarean delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0204",
    "Questions": "Which measure reduces mother-to-child transmission of HIV at delivery?",
    "A": "Elective caesarean section only",
    "B": "Exclusive breastfeeding with ART",
    "C": "Formula feeding only",
    "D": "Withholding ART",
    "Answer": "B",
    "Comment": "Exclusive breastfeeding with ART significantly reduces HIV transmission.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0205",
    "Questions": "What is the management of mild anaemia in pregnancy?",
    "A": "No intervention",
    "B": "Blood transfusion",
    "C": "Oral iron and folate supplementation",
    "D": "IV antibiotics",
    "Answer": "C",
    "Comment": "Mild anaemia is managed with oral iron and folate supplementation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0206",
    "Questions": "Which of the following increases risk of postpartum depression?",
    "A": "Strong family support",
    "B": "History of psychiatric illness",
    "C": "Access to mental health care",
    "D": "Planned pregnancy",
    "Answer": "B",
    "Comment": "Past psychiatric history increases risk of postpartum depression.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0207",
    "Questions": "Which hypertensive disorder is defined as new hypertension after 20 weeks without proteinuria?",
    "A": "Chronic hypertension",
    "B": "Gestational hypertension",
    "C": "Pre-eclampsia",
    "D": "Secondary hypertension",
    "Answer": "B",
    "Comment": "Gestational hypertension is diagnosed after 20 weeks without proteinuria.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0208",
    "Questions": "Which of the following is the most effective emergency management of postpartum haemorrhage?",
    "A": "Delay until senior review",
    "B": "Immediate uterotonic drugs and uterine massage",
    "C": "Oral fluids and reassurance",
    "D": "Antibiotics only",
    "Answer": "B",
    "Comment": "Immediate use of uterotonic drugs and massage is essential.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0209",
    "Questions": "What is the first-line management of epilepsy in pregnancy?",
    "A": "Avoid medication",
    "B": "Phenytoin",
    "C": "Lamotrigine or sodium valproate",
    "D": "Carbamazepine",
    "Answer": "C",
    "Comment": "Lamotrigine or valproate are commonly used but valproate should be avoided if possible.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0210",
    "Questions": "Which maternal infection requires screening and treatment to prevent congenital anomalies?",
    "A": "Syphilis",
    "B": "Malaria",
    "C": "HIV",
    "D": "Chlamydia",
    "Answer": "A",
    "Comment": "Syphilis screening and treatment prevents congenital anomalies and stillbirth.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0211",
    "Questions": "Which of the following defines secondary postpartum haemorrhage?",
    "A": "Bleeding within 24 hours after delivery",
    "B": "Bleeding after 24 hours up to 12 weeks postpartum",
    "C": "Bleeding during caesarean only",
    "D": "Bleeding at time of miscarriage",
    "Answer": "B",
    "Comment": "Secondary PPH occurs after 24 hours up to 12 weeks postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0212",
    "Questions": "Which of the following is the leading cause of maternal death in South Africa?",
    "A": "Postpartum haemorrhage",
    "B": "Hypertensive disorders",
    "C": "HIV-related conditions",
    "D": "Sepsis",
    "Answer": "C",
    "Comment": "HIV-related conditions remain the leading cause of maternal mortality in South Africa.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0213",
    "Questions": "What is the most appropriate management of severe pre-eclampsia at 32 weeks?",
    "A": "Continue pregnancy with close observation",
    "B": "Immediate delivery after stabilisation",
    "C": "Bed rest until 37 weeks",
    "D": "Oral antihypertensives only",
    "Answer": "B",
    "Comment": "Definitive treatment of severe pre-eclampsia is delivery after maternal stabilisation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0214",
    "Questions": "What is the definition of puerperal sepsis?",
    "A": "Infection of the genital tract from miscarriage only",
    "B": "Infection of the genital tract from onset of rupture of membranes to 42 days postpartum",
    "C": "Any infection after 1 year",
    "D": "Infection restricted to caesarean wounds",
    "Answer": "B",
    "Comment": "Puerperal sepsis is infection of the genital tract from rupture of membranes to 42 days postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0215",
    "Questions": "Which of the following is a recommended intervention for small-for-gestational-age babies?",
    "A": "Routine induction at 28 weeks",
    "B": "Enhanced surveillance and Doppler studies",
    "C": "No intervention",
    "D": "Immediate caesarean section at diagnosis",
    "Answer": "B",
    "Comment": "Management of SGA babies involves close surveillance and Doppler monitoring.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0216",
    "Questions": "Which statement about breastfeeding in HIV-positive mothers is correct?",
    "A": "Breastfeeding is contraindicated",
    "B": "Exclusive breastfeeding with ART is recommended",
    "C": "Formula feeding is safer in all cases",
    "D": "Mixed feeding is encouraged",
    "Answer": "B",
    "Comment": "Exclusive breastfeeding with ART is recommended to reduce HIV transmission.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0217",
    "Questions": "Which of the following defines placenta praevia?",
    "A": "Placenta implanted in lower uterine segment covering cervix",
    "B": "Premature separation of normally implanted placenta",
    "C": "Any bleeding before labour",
    "D": "Fetal membranes rupturing early",
    "Answer": "A",
    "Comment": "Placenta praevia refers to placental tissue covering or near the cervical os.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0218",
    "Questions": "What is the most appropriate management of ectopic pregnancy in an unstable patient?",
    "A": "Methotrexate therapy",
    "B": "Expectant management",
    "C": "Laparotomy with resuscitation",
    "D": "Laparoscopic salpingostomy",
    "Answer": "C",
    "Comment": "Unstable ruptured ectopic pregnancy requires immediate laparotomy with resuscitation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0219",
    "Questions": "Which vaccine is routinely recommended during pregnancy in South Africa?",
    "A": "Yellow fever",
    "B": "Influenza and Tdap",
    "C": "Polio",
    "D": "Measles",
    "Answer": "B",
    "Comment": "Influenza and Tdap vaccines are recommended in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0220",
    "Questions": "Which of the following defines threatened miscarriage?",
    "A": "All products expelled",
    "B": "Closed cervix with vaginal bleeding",
    "C": "Open cervix with fetal expulsion",
    "D": "No bleeding but abdominal pain",
    "Answer": "B",
    "Comment": "Threatened miscarriage is vaginal bleeding with a closed cervix.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0221",
    "Questions": "Which of the following best describes respectful postnatal care?",
    "A": "Separating mother and infant routinely",
    "B": "Encouraging skin-to-skin contact",
    "C": "Transferring baby without consent",
    "D": "Withholding breastfeeding advice",
    "Answer": "B",
    "Comment": "Respectful postnatal care includes encouraging skin-to-skin contact.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0222",
    "Questions": "Which is the most common cause of secondary postpartum haemorrhage?",
    "A": "Trauma to genital tract",
    "B": "Endometritis and retained tissue",
    "C": "Hypertension",
    "D": "Coagulopathy",
    "Answer": "B",
    "Comment": "Secondary PPH is most often due to retained tissue or infection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0223",
    "Questions": "What is the appropriate management of a woman with placenta praevia presenting with bleeding at 36 weeks?",
    "A": "Immediate vaginal delivery",
    "B": "Elective caesarean delivery",
    "C": "Expectant outpatient management",
    "D": "Forceps delivery",
    "Answer": "B",
    "Comment": "Placenta praevia usually requires caesarean delivery at term.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0224",
    "Questions": "Which of the following is a complication of multiple pregnancy?",
    "A": "Reduced risk of preterm labour",
    "B": "Increased risk of fetal growth restriction",
    "C": "Reduced risk of malpresentation",
    "D": "Lower risk of anaemia",
    "Answer": "B",
    "Comment": "Multiple pregnancies carry higher risk of preterm labour and growth restriction.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0225",
    "Questions": "Which of the following defines complete miscarriage?",
    "A": "Bleeding with retained tissue",
    "B": "Bleeding with closed cervix",
    "C": "All products of conception expelled",
    "D": "Infection with sepsis",
    "Answer": "C",
    "Comment": "In complete miscarriage, all products of conception are expelled.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0226",
    "Questions": "What is the initial management of uterine inversion?",
    "A": "Immediate hysterectomy",
    "B": "Replace uterus manually",
    "C": "Delay management for theatre",
    "D": "Give only antibiotics",
    "Answer": "B",
    "Comment": "Immediate manual replacement of uterus is the first step.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0227",
    "Questions": "Which of the following is a recommended method of induction of labour with favourable cervix?",
    "A": "Mechanical methods",
    "B": "High-dose misoprostol",
    "C": "Oxytocin infusion",
    "D": "Elective caesarean",
    "Answer": "C",
    "Comment": "Oxytocin is used when cervix is favourable.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0228",
    "Questions": "What is the most common cause of perinatal mortality in South Africa?",
    "A": "Hypertensive disorders",
    "B": "HIV infection",
    "C": "Preterm birth complications",
    "D": "Birth asphyxia",
    "Answer": "C",
    "Comment": "Preterm birth complications are a leading cause of perinatal mortality.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0229",
    "Questions": "Which of the following is NOT part of active management of PPH?",
    "A": "Uterine massage",
    "B": "Immediate IV antibiotics",
    "C": "Uterotonics",
    "D": "Tranexamic acid",
    "Answer": "B",
    "Comment": "IV antibiotics are not part of active PPH management; they are used if infection is suspected.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0230",
    "Questions": "Which of the following defines inevitable miscarriage?",
    "A": "Bleeding with closed cervix",
    "B": "Bleeding with open cervix and products visible",
    "C": "No bleeding but abdominal pain",
    "D": "All products expelled",
    "Answer": "B",
    "Comment": "Inevitable miscarriage is bleeding with open cervix and visible products.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0231",
    "Questions": "What is the most appropriate management of asymptomatic bacteriuria in pregnancy?",
    "A": "No treatment required",
    "B": "Oral antibiotics",
    "C": "IV antibiotics",
    "D": "Increase fluids only",
    "Answer": "B",
    "Comment": "Asymptomatic bacteriuria requires oral antibiotics to prevent pyelonephritis.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0232",
    "Questions": "Which antihypertensive is safe for use in pregnancy?",
    "A": "ACE inhibitors",
    "B": "Methyldopa",
    "C": "Enalapril",
    "D": "Losartan",
    "Answer": "B",
    "Comment": "Methyldopa is a first-line antihypertensive safe in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0233",
    "Questions": "Which of the following is a feature of severe pre-eclampsia?",
    "A": "Mild headache only",
    "B": "Proteinuria with BP 130/80",
    "C": "Visual disturbances and elevated creatinine",
    "D": "No symptoms with mild hypertension",
    "Answer": "C",
    "Comment": "Severe pre-eclampsia involves high BP with organ dysfunction such as visual symptoms.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0234",
    "Questions": "Which of the following is the most common site for ectopic pregnancy?",
    "A": "Cervix",
    "B": "Ovary",
    "C": "Fallopian tube",
    "D": "Abdominal cavity",
    "Answer": "C",
    "Comment": "Most ectopic pregnancies occur in the fallopian tube.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0235",
    "Questions": "Which intervention is recommended in cases of chorioamnionitis?",
    "A": "Oral antibiotics only",
    "B": "Immediate delivery with IV antibiotics",
    "C": "No intervention until term",
    "D": "Bed rest only",
    "Answer": "B",
    "Comment": "Chorioamnionitis requires IV antibiotics and delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0236",
    "Questions": "What is the most important step in preventing maternal deaths?",
    "A": "Only training doctors",
    "B": "Only equipping tertiary hospitals",
    "C": "Implementing evidence-based guidelines at all levels",
    "D": "Discouraging ANC attendance",
    "Answer": "C",
    "Comment": "Maternal deaths can be reduced by applying national evidence-based guidelines widely.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0237",
    "Questions": "Which of the following is a key principle of respectful care when engaging with adolescents?",
    "A": "Judging them for early pregnancy",
    "B": "Providing gentle and supportive care",
    "C": "Denying them antenatal care",
    "D": "Separating them from adult women",
    "Answer": "B",
    "Comment": "Adolescents need non-judgmental, supportive care to encourage ANC attendance and improve outcomes.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0238",
    "Questions": "What is the most appropriate management for malaria in pregnancy?",
    "A": "No treatment required",
    "B": "Artemisinin-based combination therapy",
    "C": "Quinine only",
    "D": "Delay treatment until postpartum",
    "Answer": "B",
    "Comment": "Artemisinin-based therapies are recommended for malaria in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0239",
    "Questions": "Which of the following is an indication for intrapartum CTG monitoring?",
    "A": "Low-risk term pregnancy",
    "B": "Induction of labour",
    "C": "Preterm labour or suspected fetal compromise",
    "D": "Postnatal period",
    "Answer": "C",
    "Comment": "CTG is indicated in high-risk cases such as preterm labour or suspected compromise.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0240",
    "Questions": "Which mental health condition is most likely to present with hallucinations postpartum?",
    "A": "Postnatal depression",
    "B": "Bipolar disorder",
    "C": "Postnatal psychosis",
    "D": "Anxiety disorder",
    "Answer": "C",
    "Comment": "Postnatal psychosis can present with hallucinations and requires urgent care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0241",
    "Questions": "Which is the most common cause of maternal anaemia in South Africa?",
    "A": "Vitamin B12 deficiency",
    "B": "Iron deficiency",
    "C": "Folate deficiency",
    "D": "Chronic renal failure",
    "Answer": "B",
    "Comment": "Iron deficiency is the leading cause of maternal anaemia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0242",
    "Questions": "Which of the following is a danger sign in pregnancy requiring immediate referral?",
    "A": "Mild ankle swelling",
    "B": "Occasional nausea",
    "C": "Severe headache and blurred vision",
    "D": "Mild fatigue",
    "Answer": "C",
    "Comment": "Severe headache and blurred vision may indicate pre-eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0243",
    "Questions": "Which contraceptive method can be safely initiated immediately postpartum?",
    "A": "Combined oral contraceptive",
    "B": "Progestogen-only implant",
    "C": "Estrogen patch",
    "D": "Intrauterine device in all cases",
    "Answer": "B",
    "Comment": "Progestogen-only methods can be safely initiated immediately postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0244",
    "Questions": "Which of the following defines postpartum sepsis?",
    "A": "Any fever after delivery",
    "B": "Genital tract infection within 42 days after birth",
    "C": "UTI during pregnancy only",
    "D": "Common cold after labour",
    "Answer": "B",
    "Comment": "Postpartum sepsis refers to genital tract infection within 42 days postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0245",
    "Questions": "Which is the most appropriate management of severe postpartum haemorrhage unresponsive to uterotonics?",
    "A": "Observation only",
    "B": "Uterine massage only",
    "C": "Uterine balloon tamponade or surgical intervention",
    "D": "Discharge home with iron supplements",
    "Answer": "C",
    "Comment": "When uterotonics fail, balloon tamponade or surgery may be required.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0246",
    "Questions": "Which of the following is the most important prevention strategy for obstetric fistula?",
    "A": "Early caesarean section for all",
    "B": "Preventing prolonged obstructed labour",
    "C": "Delaying first pregnancy",
    "D": "Use of high-dose oxytocin indiscriminately",
    "Answer": "B",
    "Comment": "Preventing prolonged obstructed labour is key to preventing obstetric fistula.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0247",
    "Questions": "Which of the following describes Tocophobia?",
    "A": "Fear of pregnancy",
    "B": "Abnormal persistent fear of childbirth",
    "C": "Postnatal depression",
    "D": "Obsession with neonatal health",
    "Answer": "B",
    "Comment": "Tocophobia is an abnormal, persistent fear of childbirth.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0248",
    "Questions": "Which condition is most strongly associated with neonatal death?",
    "A": "Preterm birth",
    "B": "Term vaginal delivery",
    "C": "Elective caesarean section",
    "D": "Post-term birth",
    "Answer": "A",
    "Comment": "Preterm birth is strongly associated with neonatal mortality.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0249",
    "Questions": "What is the first-line antibiotic for urinary tract infection in pregnancy?",
    "A": "Ciprofloxacin",
    "B": "Amoxicillin or cephalexin",
    "C": "Tetracycline",
    "D": "Doxycycline",
    "Answer": "B",
    "Comment": "Amoxicillin or cephalexin are safe first-line antibiotics in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0250",
    "Questions": "Which of the following defines recurrent miscarriage?",
    "A": "Two or more consecutive miscarriages",
    "B": "Three or more consecutive miscarriages",
    "C": "One miscarriage after 20 weeks",
    "D": "Any miscarriage before 12 weeks",
    "Answer": "B",
    "Comment": "Recurrent miscarriage is defined as three or more consecutive losses.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0251",
    "Questions": "Which of the following is recommended for mothers experiencing Baby Blues?",
    "A": "SSRIs immediately",
    "B": "Compassionate support and monitoring",
    "C": "Electroconvulsive therapy",
    "D": "Benzodiazepines",
    "Answer": "C",
    "Comment": "Baby Blues usually resolve with support; careful monitoring is important.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0252",
    "Questions": "Which antiretroviral drug should be avoided in the first trimester due to risk of neural tube defects?",
    "A": "Dolutegravir",
    "B": "Tenofovir",
    "C": "Lamivudine",
    "D": "Efavirenz",
    "Answer": "A",
    "Comment": "Dolutegravir is avoided in the first trimester due to neural tube defect risk.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0253",
    "Questions": "What is the recommended management of prolonged pregnancy (>41 weeks)?",
    "A": "No intervention until 43 weeks",
    "B": "Induction of labour",
    "C": "Elective caesarean at 38 weeks",
    "D": "Discharge until labour starts naturally",
    "Answer": "B",
    "Comment": "Induction of labour is recommended for prolonged pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0254",
    "Questions": "Which of the following is the safest analgesia for asthma in pregnancy?",
    "A": "Aspirin",
    "B": "NSAIDs",
    "C": "Paracetamol",
    "D": "High-dose morphine",
    "Answer": "C",
    "Comment": "Paracetamol is safe for pain relief in asthmatic pregnant women.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0255",
    "Questions": "Which infection requires IPTp (intermittent preventive treatment) in pregnancy?",
    "A": "HIV",
    "B": "Tuberculosis",
    "C": "Malaria",
    "D": "Syphilis",
    "Answer": "C",
    "Comment": "Malaria prevention during pregnancy includes intermittent preventive treatment in endemic areas.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0256",
    "Questions": "Which of the following is a contraindication to induction of labour at district hospital level?",
    "A": "Hypertension",
    "B": "Previous caesarean section",
    "C": "Post-term pregnancy",
    "D": "Preterm labour",
    "Answer": "B",
    "Comment": "Previous caesarean section is a contraindication to IOL at district level.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0257",
    "Questions": "Which of the following is part of respectful care when communicating across language barriers?",
    "A": "Use of hostile tone",
    "B": "Refusing to treat patient",
    "C": "Using simple sentences and translation",
    "D": "Only treating if interpreter is available",
    "Answer": "C",
    "Comment": "Simple communication, translation, and visual aids improve respectful care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0258",
    "Questions": "What is the first-line management for an HIV-exposed infant after birth?",
    "A": "No prophylaxis needed",
    "B": "Nevirapine prophylaxis",
    "C": "Immediate ART initiation",
    "D": "Formula feeding only",
    "Answer": "B",
    "Comment": "HIV-exposed infants should receive nevirapine prophylaxis.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0259",
    "Questions": "Which of the following is the most effective immediate management of eclampsia?",
    "A": "IV fluids only",
    "B": "Magnesium sulphate",
    "C": "Diazepam and oxygen",
    "D": "Antihypertensives only",
    "Answer": "B",
    "Comment": "Magnesium sulphate is the immediate management for eclampsia seizures.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0260",
    "Questions": "What is the recommended first-line management of gestational diabetes?",
    "A": "Insulin therapy for all",
    "B": "Diet and lifestyle modification",
    "C": "Oral hypoglycaemic agents always",
    "D": "No treatment needed",
    "Answer": "B",
    "Comment": "Diet and lifestyle are first-line; insulin is added if inadequate.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0261",
    "Questions": "Which of the following defines complete placenta praevia?",
    "A": "Placenta implanted low but not covering cervix",
    "B": "Placenta entirely covering cervical os",
    "C": "Placenta implanted normally",
    "D": "Placenta covering only uterine wall",
    "Answer": "B",
    "Comment": "Complete placenta praevia means placenta fully covers the cervical os.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "PaedsTB0262",
    "Questions": "What percentage of the estimated 27000 children with TB in South Africa were notified and reported to the WHO in 2022?",
    "A": 0.39,
    "B": 0.51,
    "C": 0.61,
    "D": 0.93,
    "Answer": "C",
    "Comment": "In 2022,  South Africa reported 16534 child TB notifications which accounts for 61% of the estimated 27000 children with TB in the country[cite: 30].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0263",
    "Questions": "According to the guideline which of the following is a key update in the revised South African recommendations?",
    "A": "The use of a clinical treatment decision algorithm to support clinicians at the tertiary level.",
    "B": "The use of additional specimens to confirm a diagnosis of TB in children.",
    "C": "A new focus on treatment lengthening for non-severe forms of TB.",
    "D": "The exclusive use of the Tuberculin Skin Test (TST) for diagnosis.",
    "Answer": "B",
    "Comment": "The new South African recommendations include key updates such as the use of additional specimens for diagnosis and a clinical treatment decision algorithm for primary health care clinicians[cite: 6, 7]",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0264",
    "Questions": "Which term has replaced 'latent TB' in the updated guidelines for children and adolescents?",
    "A": "TB disease",
    "B": "Presumptive TB",
    "C": "TB infection",
    "D": "Significant TB exposure",
    "Answer": "C",
    "Comment": "The term latent TB has been replaced by the term TB infection as children are mostly recently infected",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0265",
    "Questions": "What is the definition of 'Significant TB Exposure' according to the guideline?",
    "A": "Exposure for at least 1 night or frequent daytime periods to a TB source patient within the last 3 months.",
    "B": "Exposure within 12 months to a TB source patient who started treatment >3 months ago.",
    "C": "Any exposure to a TB source patient within the last 6 months.",
    "D": "Exposure within 12 months to a TB source patient in the same enclosed space for ??� 1 night or frequent daytime periods during the three months before the source patient started TB treatment.",
    "Answer": "D",
    "Comment": "Significant TB Exposure is defined as \"Exposure within the 12 months before the child/adolescent presents with presumed TB to a person (adult or adolescent) with pulmonary TB within the same enclosed space for ??� 1 night... or for frequent or extended daytime periods... during the three months before the source/index patient started TB treatment\"[cite: 46].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0266",
    "Questions": "Which of the following is NOT one of the \"puzzle pieces\" used to construct a TB diagnosis in children and adolescents?",
    "A": "Patient history",
    "B": "Clinical examination",
    "C": "Socio-economic status",
    "D": "HIV status",
    "Answer": "C",
    "Comment": "The 'puzzle pieces' include patient history, clinical examination, HIV status, CXR, and diagnostic testing[cite: 481]",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0267",
    "Questions": "A child is considered to have 'presumptive TB' when:?",
    "A": "The diagnosis of TB is bacteriologically confirmed.",
    "B": "TB is considered a possible cause of illness based on symptoms or signs.",
    "C": "The child has a positive TST result.",
    "D": "The child has a history of significant TB exposure.",
    "Answer": "B",
    "Comment": "A child or adolescent is believed to have presumptive TB when TB is considered a possible cause of illness in those who present with symptoms or signs suggestive of TB[cite: 51].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0268",
    "Questions": "What is the most common form of TB in children in high TB incidence countries like South Africa?",
    "A": "Extrapulmonary TB (EPT",
    "B": "Miliary TB",
    "C": "Pulmonary TB (PT",
    "D": "TB meningitis",
    "Answer": "C",
    "Comment": "Pulmonary TB (PT is the most common form of TB in children[cite: 428].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0269",
    "Questions": "Which of the following is a reason why TB in children is more difficult to diagnose bacteriologically compared to adults?",
    "A": "Children typically have a higher bacillary load.",
    "B": "Specimen collection is easier in children.",
    "C": "Children have paucibacillary disease with fewer bacilli.",
    "D": "The radiological picture is the same as in adults.",
    "Answer": "C",
    "Comment": "Younger children tend to have few detectable bacilli in their sputum/other respiratory specimens (paucibacillary disease) which makes detecting and confirming TB bacteriologically more difficult[cite: 429].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0270",
    "Questions": "According to the guideline the BCG vaccine is especially protective against which forms of TB?",
    "A": "Drug-resistant TB",
    "B": "Paucibacillary disease",
    "C": "Extrapulmonary TB",
    "D": "Severe forms of TB in infants and young children",
    "Answer": "D",
    "Comment": "The BCG vaccine is not fully protective against TB disease but is especially protective against severe forms of TB in infants and young children[cite: 434].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0271",
    "Questions": "What is the recommended intensive phase duration for the treatment of drug-susceptible TB in children?",
    "A": "1 month",
    "B": "2 months",
    "C": "4 months",
    "D": "6 months",
    "Answer": "B",
    "Comment": "The treatment consists of an intensive phase of 2 months[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0272",
    "Questions": "What is the recommended continuation phase duration for the treatment of non-severe PTB and/or cervical TB lymphadenitis if the child meets the eligibility criteria for treatment shortening?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "A",
    "Comment": "In the patient with non-severe PTB and/or cervical TB lymphadenitis the continuation phase is two months provided the child meets the eligibility criteria for treatment shortening[cite: 137].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0273",
    "Questions": "What is the typical duration of the continuation phase for children with bone and joint TB?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "D",
    "Comment": "In children with bone and joint TB the duration of the continuation phase is typically prolonged up to 10 months or even longer in specific circumstances[cite: 139].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0274",
    "Questions": "Which of the following is NOT a component of the comprehensive package of care for TB?",
    "A": "Providing anti-TB treatment.",
    "B": "Identifying adult TB source patients.",
    "C": "Providing psychosocial support.",
    "D": "Prescribing antibiotics for all concurrent illnesses.",
    "Answer": "D",
    "Comment": "The components of a comprehensive package of care for TB include providing anti-TB treatment identifying adult TB source patients preventing and managing co-morbid illnesses and providing psychosocial support[cite: 82 83].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0275",
    "Questions": "What is the main reason for patients discontinuing medications as stated in the guideline?",
    "A": "Lack of patient education",
    "B": "Inadequate management of side effects and adverse events",
    "C": "Poor psychosocial support",
    "D": "High cost of medication",
    "Answer": "B",
    "Comment": "Inadequate management of side effects and adverse events is the main reason patients discontinue medications and one of the primary reasons for treatment failure",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0276",
    "Questions": "Which of the following drugs is NOT listed as a potential cause of hepatotoxicity in children?",
    "A": "Isoniazid",
    "B": "Rifampicin",
    "C": "Pyrazinamide",
    "D": "Ethambutol",
    "Answer": "D",
    "Comment": "The most important adverse event on first-line medication is hepatotoxicity which can be caused by isoniazid rifampicin or pyrazinamide and very rarely by ethambutol[cite: 273]. which can be caused by isoniazid rifampicin or pyrazinamide and very rarely by ethambutol[cite: 273].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0277",
    "Questions": "When should bacteriological monitoring be re-evaluated for a child on TB treatment?",
    "A": "Every 2 weeks",
    "B": "If there is clinical deterioration or new exposure to a DR-TB source patient.",
    "C": "Only at the end of treatment.",
    "D": "Never, as it is rarely implemented in children",
    "Answer": "B",
    "Comment": "Re-evaluating the bacteriological status of a child becomes a priority if there is clinical deterioration or if there is a new exposure to a source patient with DR-TB[cite: 270].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0278",
    "Questions": "For a child on a four or six-month regimen what is the management for a cumulative treatment interruption of less than one month?",
    "A": "Start the regimen over from the beginning.",
    "B": "Add additional doses to the end of the relevant treatment phase.",
    "C": "Switch to a different regimen.",
    "D": "Stop treatment entirely.",
    "Answer": "B",
    "Comment": "For a cumulative interruption of less than 1 month add additional doses to the end of the relevant treatment phase[cite: 289].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0279",
    "Questions": "Which of the following statements about TB in children is correct?",
    "A": "They typically have a higher bacillary load than adults.",
    "B": "They usually develop TB within 24 months of exposure.",
    "C": "They may have a broad differential diagnosis for their symptoms.",
    "D": "They do not require a Chest X-ray for diagnosis.",
    "Answer": "C",
    "Comment": "Symptoms in children may be vague and may have a broad differential diagnosis[cite: 438].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0280",
    "Questions": "What is the Ghon complex?",
    "A": "The combination of a parenchymal focus in the lung and the nearest mediastinal lymph node.",
    "B": "The initial site of mycobacterial multiplication in the lung.",
    "C": "The spread of TB bacilli via the lymphatic system.",
    "D": "A form of extrapulmonary TB.",
    "Answer": "A",
    "Comment": "The Ghon complex is formed by the parenchymal focus in the lung and the nearest mediastinal lymph node[cite: 447].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0281",
    "Questions": "What are the risk factors for developing severe TB disease after exposure/infection in children?",
    "A": "Older age and being HIV negative.",
    "B": "Younger age, living with HIV, and/or having severe malnutrition",
    "C": "Being HIV positive but well-nourished.",
    "D": "Being an adolescent with adult-type TB.",
    "Answer": "B",
    "Comment": "Being of younger age living with HIV or HIV exposure and/or having severe malnutrition are all risk factors for developing TB disease after TB exposure/infection[cite: 432]. living with HIV or HIV exposure and/or having severe malnutrition are all risk factors for developing TB disease after TB exposure/infection[cite: 432].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0282",
    "Questions": "Which of the following is a key update in the revised South African guidelines mentioned in the foreword?",
    "A": "A focus on increasing the number of TB notifications in adults.",
    "B": "Practical guidance on treatment shortening for non-severe forms of TB in children and adolescents.",
    "C": "The use of a new anti-TB drug not yet approved by the WHO.",
    "D": "Exclusive reliance on bacteriological confirmation for diagnosis.",
    "Answer": "B",
    "Comment": "One of the key updates is \"practical guidance on implementation of treatment shortening for non-severe forms of TB in children and adolescents\"[cite: 6 7].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0283",
    "Questions": "What is the recommended management for a child who deteriorates on TB treatment or has treatment failure?",
    "A": "Continue the current regimen for a longer duration.",
    "B": "Refer the child to the next level of care for further assessment and management.",
    "C": "Stop all anti-TB medication immediately.",
    "D": "Switch to a different anti-TB regimen without further investigation.",
    "Answer": "B",
    "Comment": "Any child with persistent symptoms or who deteriorates on TB treatment should be referred to the next level of care for further assessment and management[cite: 285].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0284",
    "Questions": "Which of the following is NOT a routine monitoring test for children and adolescents on ART as per the guideline?",
    "A": "Weight and height",
    "B": "CD4 count",
    "C": "Liver function tests",
    "D": "Serum creatinine",
    "Answer": "C",
    "Comment": "Table 14 lists routine monitoring tests for children on ART as weight/height CD4 count VL creatinine FBC and electrolytes. Liver function tests are listed under a different heading (DILI)[cite: 13",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0285",
    "Questions": "What is the minimum level of integration primary care facilities should provide for a mother-child pair on the same day?",
    "A": "Level 1: Integrated care in one consulting room.",
    "B": "Level 2: Aligning visit schedules to attend the same facility on the same day.",
    "C": "Level 3: All needed care in the same room by the same provider.",
    "D": "No integration is necessary,  as long as care is provided.",
    "Answer": "A",
    "Comment": "Primary care facilities should at a minimum provide Level 1 integration[cite: 258].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0286",
    "Questions": "Which of the following statements about adolescents with TB is true?",
    "A": "They typically have paucibacillary disease.",
    "B": "Bacteriological confirmation is less likely than in younger children.",
    "C": "Their presentation and diagnostic approach are similar to adults.",
    "D": "They are not at risk for extrapulmonary TB.",
    "Answer": "C",
    "Comment": "The presentation of and approach to diagnosing PTB in adolescents (10-19 years) is similar to that for adults[cite: 435].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0287",
    "Questions": "Which two drug classes have significant drug interactions with rifampicin that reduce their blood concentrations?",
    "A": "NSAIDs and Paracetamol",
    "B": "Antihistamines and Beta-blockers",
    "C": "Antiretroviral drugs and oral contraceptives",
    "D": "Antiretroviral drugs and oral hypoglycaemic agents",
    "Answer": "C",
    "Comment": "Rifampicin has significant drug interactions with antiretroviral drugs that reduce ART concentrations in the blood and adolescents should be provided with contraception as appropriate due to these drug interactions[cite: 102 118].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0288",
    "Questions": "According to the guidelines when should a decision to start TB treatment NOT be delayed?",
    "A": "When a TST is positive,  but other tests are pending.",
    "B": "When a TST is positive,  but other tests are pending.",
    "C": "When the child is over 10 years of age and clinically stable.",
    "D": "When a social worker has not yet completed the home visit.",
    "Answer": "A",
    "Comment": "A decision to start TB treatment should not be delayed if the necessary investigations are not available, particularly in children at higher risk of developing severe disease, such as young children, malnourished children or those living with HIV[cite: 75].A decision to start TB treatment should not be delayed if the necessary investigations are not available, particularly in children at higher risk of developing severe disease, such as young children, malnourished children or those living with HIV[cite: 75].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0289",
    "Questions": "What is a key difference between TB in children and adults?",
    "A": "Children have a higher risk of poor outcomes if treated early.",
    "B": "The pathophysiology and clinical picture are identical.",
    "C": "Children have very good outcomes if started on appropriate treatment timeously.",
    "D": "Specimen collection is easier in children.",
    "Answer": "C",
    "Comment": "Children have very good outcomes if started on appropriate treatment timeously but the highest risk of poor outcomes if not treated[cite: 439].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0290",
    "Questions": "In the pathophysiology of TB what is the term for the initial parenchymal focus in the lung?",
    "A": "The Ghon complex",
    "B": "The primary focus or Ghon focus",
    "C": "The mediastinal lymph node",
    "D": "The pleural effusion",
    "Answer": "B",
    "Comment": "The initial parenchymal focus in the lung is called the primary focus or Ghon focus[cite: 446].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0291",
    "Questions": "Which of the following is a symptom of Pulmonary TB (PT listed in the document?",
    "A": "Diarrhoea",
    "B": "Persistent cough",
    "C": "Joint pain",
    "D": "Skin rash",
    "Answer": "B",
    "Comment": "Table 2 lists persistent cough (>2 weeks) as a symptom of Pulmonary TB[cite: 3].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0292",
    "Questions": "According to the guideline what is the recommended management of a child with miliary tuberculosis?",
    "A": "Treatment is not delayed,  and the drug regimen is the same as for TBM.",
    "B": "Treatment is delayed until bacteriological confirmation is obtained.",
    "C": "The drug regimen is the same as for non-severe PTB.",
    "D": "Corticosteroids are contraindicated.",
    "Answer": "A",
    "Comment": "Treatment should not be delayed while waiting for results; the anti-tuberculosis drug regimen is the same as for TBM[cite: 174].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0293",
    "Questions": "What is the recommended approach to breastfeeding for a mother being treated for TB?",
    "A": "Breastfeeding is not recommended.",
    "B": "Breastfeeding should be stopped.",
    "C": "Breastfeeding should be encouraged for all mothers still able to breastfeed.",
    "D": "Breastfeeding is only recommended for mothers with non-severe TB.",
    "Answer": "C",
    "Comment": "Breastfeeding should be encouraged for all mothers still able to breastfeed[cite: 117].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0294",
    "Questions": "What is the definition of a 'clinical diagnosis of TB'?",
    "A": "A diagnosis confirmed by a positive culture result.",
    "B": "A diagnosis based on history,  clinical findings,  and/or radiological features.",
    "C": "A diagnosis made when all bacteriological tests are positive.",
    "D": "A diagnosis made only in the absence of radiological features.",
    "Answer": "B",
    "Comment": "A diagnosis made on the grounds of history, clinical findings, radiological features, exposure history, growth trend, or a combination of the above, and where bacteriological tests were either not performed or the results were negative[cite: 52].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0295",
    "Questions": "When should a child with a known TB exposure be considered for TB preventive treatment (TPT)?",
    "A": "When they have no symptoms and no radiological changes on CXR.",
    "B": "Only if they are also living with HIV.",
    "C": "Never",
    "D": "as TPT is not part of the guideline.",
    "Answer": "B",
    "Comment": "Children with no symptoms and no radiological changes on CXR are classified as having TB infection (previously termed ???latent??? T and should be considered for TB preventive treatment (TPT)[cite: 449 450].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0296",
    "Questions": "In the context of the TB/HIV co-infected patient the guideline states that TB cannot be treated without also treating HIV. What is the reciprocal statement?",
    "A": "HIV can be treated without also treating TB.",
    "B": "HIV cannot be treated without also treating TB.",
    "C": "ART must be stopped during TB treatment.",
    "D": "TB treatment must be delayed until ART is started.",
    "Answer": "B",
    "Comment": "The guideline explicitly states: \"In a TB/HIV co-infected patient TB cannot be treated without also treating HIV and HIV cannot be treated without also treating TB!\"[cite: 104].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0297",
    "Questions": "Which of the following is a danger sign in a child with TB needing urgent attention?",
    "A": "Persistent cough for >2 weeks",
    "B": "Loss of appetite",
    "C": "Convulsions",
    "D": "Failure to thrive",
    "Answer": "C",
    "Comment": "Box 1 lists convulsions as a danger sign needing urgent attention[cite: 11].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0298",
    "Questions": "What is the recommended medication for supplemental pyridoxine?",
    "A": "Vitamin D",
    "B": "Pyridoxine",
    "C": "Zinc",
    "D": "Iron",
    "Answer": "B",
    "Comment": "Section 9.2 is titled \"Supplemental pyridoxine\" and lists the drug name[cite: 43].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0299",
    "Questions": "According to the guideline which of the following is NOT a reason for the link between TB and malnutrition?",
    "A": "Malnutrition reduces cell-mediated immunity,  increasing the risk of TB disease.",
    "B": "The catabolic effect of TB disease results in weight loss.",
    "C": "Malnutrition makes TB treatment drugs less effective.",
    "D": "TB disease worsens malnutrition.",
    "Answer": "C",
    "Comment": "Box 5 lists malnutrition's effect on immunity and the catabolic effect of TB disease as reasons for the link between TB and malnutrition[cite: 119].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0300",
    "Questions": "When should the BCG vaccine be repeated in an infant who initiated TPT or TB treatment in the first 6 weeks of life?",
    "A": "After completion of TPT or TB treatment",
    "B": "Never,  as it is a one-time vaccine.",
    "C": "Before TPT or TB treatment is started.",
    "D": "At 6 months of age,  regardless of treatment completion.",
    "Answer": "A",
    "Comment": "BCG should be repeated after completion of TPT or TB treatment[cite: 219].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0301",
    "Questions": "What is the recommended TB drug regimen for a child under three months of age weighing less than 3 kg given the challenges with ethambutol administration?",
    "A": "Isoniazid and Rifampicin",
    "B": "Isoniazid, Rifampicin, Pyrazinamide and Ethambutol",
    "C": "Isoniazid, Rifampicin, Pyrazinamide and Ethionamide",
    "D": "The regimen should be delayed until the child is older.",
    "Answer": "C",
    "Comment": "...ethionamide can be considered in infants younger than three months or weighing < 3kg, given the challenges with ethambutol administration and monitoring for ocular toxicity in the very young[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0302",
    "Questions": "In children with presumed or confirmed DS-TBM what is the recommended management for hyponatremia?",
    "A": "Restrict fluid intake",
    "B": "Encourage fluid intake",
    "C": "Administer IV fluids",
    "D": "Administer oral salt tablets",
    "Answer": "A",
    "Comment": "Table 10 recommends restricting fluids for hyponatremia due to SIADH[cite: 16].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0303",
    "Questions": "What is the recommended approach to Tuberculin Skin Test (TST) in the diagnostic process?",
    "A": "It is the first and only test needed.",
    "B": "It is only useful if there is no known TB exposure.",
    "C": "It is used to confirm bacteriological diagnosis.",
    "D": "It is a replacement for the chest X-ray.",
    "Answer": "B",
    "Comment": "The TST is only useful if no known TB exposure[cite: 62].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0304",
    "Questions": "Which of the following is NOT a routine TB programme activity that should be completed for monitoring and evaluation purposes?",
    "A": "Recording and reporting",
    "B": "Bacteriological monitoring",
    "C": "Identifying adult TB source patients",
    "D": "Assessing post-TB health",
    "Answer": "B",
    "Comment": "Bacteriological monitoring is a part of patient monitoring but recording reporting identifying source patients and assessing post-TB health are listed as routine programme activities[cite: 83].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0305",
    "Questions": "According to the guideline which of the following statements about drug adverse events in children is true?",
    "A": "They are more common in children than in adults.",
    "B": "Hepatotoxicity is rare,  occurring in less than 5% of children on first-line medication.",
    "C": "Hepatotoxicity is most likely to occur after 6 months of treatment.",
    "D": "All adverse events require hospitalisation.",
    "Answer": "B",
    "Comment": "Adverse events caused by TB medications are less common in children than in adults and \"Hepatotoxicity... are rare (5% or lower) in children\"[cite: 272 274]. 274].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0306",
    "Questions": "The guideline suggests that for adolescents the approach to diagnosing PTB is similar to that of adults. What is a key reason for this similarity?",
    "A": "They have paucibacillary disease.",
    "B": "They are less likely to have EPTB.",
    "C": "Bacteriological confirmation is more likely.",
    "D": "They are not at risk for severe TB.",
    "Answer": "C",
    "Comment": "Bacteriological confirmation is more likely in adolescents who often have adult-type (cavitary) PTB disease[cite: 436].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0307",
    "Questions": "Which of the following is a common Chest X-ray feature in perinatal TB?",
    "A": "Cavities",
    "B": "Pleural effusion",
    "C": "Miliary infiltrates",
    "D": "Normal chest x-ray",
    "Answer": "C",
    "Comment": "Table 12 lists miliary infiltrates as a common Chest X-ray feature occurring in 30-40% of cases[cite: 190].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0308",
    "Questions": "What is the recommended initial TB treatment regimen for a child with presumed or confirmed DS-TBM?",
    "A": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 4 months.",
    "B": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 7 months.",
    "C": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 10 months.",
    "D": "The guideline defers to a specialist.",
    "Answer": "A",
    "Comment": "Table 9 on page 45 shows a 2 month intensive phase and a 10 month continuation phase[cite: 1718 19]. shows a 2 month intensive phase and a 10 month continuation phase[cite: 17",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0309",
    "Questions": "What is the main reason for the increased risk of disengagement and loss-to-follow-up (LTF) in TB management?",
    "A": "Inadequate psychosocial support.",
    "B": "Failure to combine care into an integrated package.",
    "C": "High cost of treatment.",
    "D": "Lack of patient education.",
    "Answer": "B",
    "Comment": "Failure to combine care leads to increased visit schedules and significantly increases the risk of disengagement and loss-to-follow-up (LTF)[cite: 88].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0310",
    "Questions": "When should a healthcare professional seek immediate care for a child on TB treatment?",
    "A": "If the child has a persistent cough.",
    "B": "If the child develops jaundice,  abdominal pain or vomiting.",
    "C": "If the child has a mild fever.",
    "D": "If the child has a loss of appetite.",
    "Answer": "B",
    "Comment": "The guideline instructs to seek immediate care if the child develops jaundice abdominal pain or vomiting[cite: 125].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0311",
    "Questions": "What is the primary role of the Road to Health Booklet (RTH in TB management?",
    "A": "To serve as a legal document for TB treatment.",
    "B": "To provide a list of all TB drugs.",
    "C": "To document all relevant information regarding the child's TB diagnosis and treatment.",
    "D": "To replace the TB treatment register.",
    "Answer": "C",
    "Comment": "It is important to always take the RTHB along for any healthcare visits as it documents all relevant information regarding the child's TB diagnosis and treatment[cite: 128 129].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0312",
    "Questions": "Which of the following is a consideration for TB treatment in co-infected children?",
    "A": "They are considered to have non-severe HIV disease.",
    "B": "They are at a lower risk of developing severe disease.",
    "C": "They are at the highest risk of death if not treated.",
    "D": "They can be treated without also treating HIV.",
    "Answer": "C",
    "Comment": "CALHIV and TB are at the highest risk of death if not treated[cite: 100].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0313",
    "Questions": "Which of the following tests should NOT be used to monitor response to treatment?",
    "A": "Smear microscopy",
    "B": "Culture",
    "C": "NAAT testing",
    "D": "Clinical examination",
    "Answer": "C",
    "Comment": "NAAT testing should NOT be used to monitor response to treatment[cite: 269].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0314",
    "Questions": "In the management of a newborn exposed to TB when should the infant be separated from the mother for infection control?",
    "A": "If the mother is known to be contagious.",
    "B": "For the first 24 hours after birth.",
    "C": "When the infant develops symptoms of TB.",
    "D": "Separation is not recommended,  even if the mother is still contagious.",
    "Answer": "D",
    "Comment": "It is not recommended that infants be separated from their mothers after birth even if the mother is known to still be contagious[cite: 200].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0315",
    "Questions": "Which of the following is a definition of bacteriologically confirmed TB?",
    "A": "Diagnosis based on a positive TST and CXR.",
    "B": "Diagnosis confirmed by clinical findings and exposure history.",
    "C": "Diagnosis confirmed using genotypic testing (TB-NAAT),  mycobacterial culture,  and/or smear microscopy.",
    "D": "Diagnosis made in the absence of bacteriological tests.",
    "Answer": "C",
    "Comment": "Bacteriologically confirmed TB is when the diagnosis of TB disease is confirmed using genotypic testing (TB-NAAT) mycobacterial culture and/or smear microscopy for acid-fast bacilli (AF[cite: 53].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0316",
    "Questions": "Which type of TB is defined as involving organs other than the lungs airways and intrathoracic lymph nodes?",
    "A": "Pulmonary TB",
    "B": "Miliary TB",
    "C": "Drug-susceptible TB",
    "D": "Extrapulmonary TB",
    "Answer": "D",
    "Comment": "Extrapulmonary TB is defined as \"any bacteriologically confirmed or clinically diagnosed patient with TB involving organs other than the lungs airways and intrathoracic lymph nodes\"[cite: 55].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0317",
    "Questions": "In adolescents which type of TB disease is most likely to be bacteriologically confirmed?",
    "A": "Paucibacillary disease",
    "B": "Adult-type (cavitary) PTB disease",
    "C": "Extrapulmonary TB",
    "D": "TB infection",
    "Answer": "B",
    "Comment": "Bacteriological confirmation is more likely in adolescents who often have adult-type (cavitary) PTB disease[cite: 436].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0318",
    "Questions": "What is the typical duration of the intensive phase for all children and adolescents with DS-TB (excluding TBM other forms of CNS TB and miliary T?",
    "A": "1 month",
    "B": "2 months",
    "C": "4 months",
    "D": "6 months",
    "Answer": "B",
    "Comment": "All children and adolescents with DS-TB (excluding TBM other forms of CNS TB and miliary T will initiate the same intensive phase of TB treatment using four anti-TB medications. The duration is 2 months[cite: 136 137].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0319",
    "Questions": "What is the recommended management of a child with Tuberculoma?",
    "A": "Anti-tuberculosis therapy is the same as for TBM.",
    "B": "Corticosteroids are not recommended.",
    "C": "A different regimen from TBM is used.",
    "D": "Treatment is only required if neurological symptoms are present.",
    "Answer": "A",
    "Comment": "Anti-tuberculosis therapy is the same as for TBM. Prednisone is also recommended[cite: 167 169].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0320",
    "Questions": "Which of the following is NOT a factor that influences the timing of ART initiation in a TB/HIV co-infected patient?",
    "A": "The specific antiretroviral drug selection.",
    "B": "The patient's age and weight.",
    "C": "Drug interactions with rifampicin.",
    "D": "Adherence due to increased pill burden.",
    "Answer": "B",
    "Comment": "The timing of ART initiation is affected by antiretroviral drug selection drug interactions with rifampicin adherence due to increased pill burden and side effects due to overlapping toxicities[cite: 101102 103].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0321",
    "Questions": "What is a key difference in TB management between children and adults as stated in the guideline?",
    "A": "Treatment is always the same for both age groups.",
    "B": "Children may have more rapid disease progression.",
    "C": "Adults have better treatment outcomes.",
    "D": "Diagnosis is easier in children.",
    "Answer": "B",
    "Comment": "CALHIV may have more rapid TB disease progression and are at higher risk of developing severe disease[cite: 99].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0322",
    "Questions": "What is the recommended drug regimen for the intensive phase of treatment for perinatal TB?",
    "A": "Isoniazid and Rifampicin",
    "B": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol or Ethionamide",
    "C": "Isoniazid, Rifampicin, and Pyrazinamide",
    "D": "Ethionamide and Rifampicin",
    "Answer": "B",
    "Comment": "The intensive phase consists of four drugs: isoniazid rifampicin and pyrazinamide and a fourth drug: either ethambutol or ethionamide[cite: 191].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0323",
    "Questions": "What is the purpose of the clinical treatment decision algorithm mentioned in the foreword?",
    "A": "To replace clinical judgement completely.",
    "B": "To enable and support clinicians at the primary health care level to start TB treatment.",
    "C": "To be used only at the tertiary level of care.",
    "D": "To determine which patients are eligible for surgery.",
    "Answer": "B",
    "Comment": "The clinical treatment decision algorithm is intended \"to enable and support clinicians at the primary health care level to start TB treatment\"[cite: 7].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0324",
    "Questions": "What is the reason given for replacing the term 'latent TB' with 'TB infection' in children?",
    "A": "Children are mostly recently infected.",
    "B": "The term 'latent' is considered outdated.",
    "C": "'TB infection' is a more accurate term for all age groups.",
    "D": "The term 'latent' is only used for adults.",
    "Answer": "A",
    "Comment": "The term ???latent TB??� has been replaced by the term ???TB infection??� as children are mostly recently infected[cite: 49].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0325",
    "Questions": "What is the main purpose of the SHINE trial mentioned in Annexure 4?",
    "A": "To study drug-resistant TB in adults.",
    "B": "To assess the efficacy of treatment shortening in children with non-severe TB.",
    "C": "To find a new drug for TB treatment.",
    "D": "To compare different diagnostic tests for TB.",
    "Answer": "B",
    "Comment": "SHINE was a multi-centre phase 3 open-label treatment-shortening non-inferiority trial in children with non-severe symptomatic smear-negative presumed drug-susceptible (DS)-TB[cite: 312].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0326",
    "Questions": "Which of the following is a correct statement about a child with TB who is on ART?",
    "A": "ART is not needed if the child is already on TB treatment.",
    "B": "ART should be stopped during TB treatment.",
    "C": "The child should be on ART, clinically well, and have a CD4% > 25 to receive a BCG",
    "D": "The BCG vaccine can be given at any time regardless of CD4",
    "Answer": "C",
    "Comment": "If the infant is also LHIV they should be on ART clinically well and have a CD4 > 25% to be able to receive BCG[cite: 219]. clinically well",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0327",
    "Questions": "What is the recommended management of a child with spinal arachnoiditis identified on an MRI?",
    "A": "It should be managed as TBM.",
    "B": "It should be managed with anti-inflammatory drugs only.",
    "C": "No treatment is necessary unless there is bone disease.",
    "D": "The regimen should be the same as for non-severe PTB.",
    "Answer": "A",
    "Comment": "If this is identified on an MRI it should be managed as TBM[cite: 171].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0328",
    "Questions": "According to the guideline what is the role of Chest X-rays in TB diagnosis?",
    "A": "It is the only puzzle piece needed for diagnosis.",
    "B": "It is a puzzle piece if available,  but not always required to start treatment.",
    "C": "It replaces the need for diagnostic testing.",
    "D": "It is only useful in adolescents.",
    "Answer": "B",
    "Comment": "The CXR is a puzzle piece used to construct a TB diagnosis if it is available[cite: 483 492]. A decision to start treatment should not be delayed if necessary investigations like a CXR are not available particularly in high-risk children[cite: 75].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0329",
    "Questions": "What is the recommended waiting period after the last anti-TB treatment dose before an infant can receive the BCG vaccine?",
    "A": "24 hours",
    "B": "5 days",
    "C": "2 months",
    "D": "6 months",
    "Answer": "A",
    "Comment": "BCG vaccination should be done 24 hours after the last anti-TB treatment dose[cite: 223].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0330",
    "Questions": "What is the recommended use of corticosteroids in children with miliary tuberculosis?",
    "A": "They are not recommended.",
    "B": "They are recommended for all children with miliary tuberculosis.",
    "C": "They are only recommended if there are neurological features.",
    "D": "Their use is not mentioned in the guideline.",
    "Answer": "B",
    "Comment": "The use of prednisone in all children with miliary tuberculosis is recommended[cite: 176].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0331",
    "Questions": "What are the components of the intensive phase of treatment for drug-susceptible PTB and EPTB (excluding TBM,  other forms of CNS TB and miliary T?",
    "A": "Isoniazid and Rifampicin, Pyrazinamide, Levofloxacin",
    "B": "Isoniazid and Rifampicin",
    "C": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol",
    "D": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol or Ethionamide",
    "Answer": "D",
    "Comment": "The intensive phase consists of 4 drugs: isoniazid rifampicin and pyrazinamide and a fourth drug which is either ethambutol or ethionamide[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0332",
    "Questions": "Which of the following is NOT a reason for providing patient education to a child/adolescent and their family?",
    "A": "To empower the patient/caregiver",
    "B": "To alleviate fear and anxiety",
    "C": "To increase the cost of treatment",
    "D": "To improve adherence",
    "Answer": "C",
    "Comment": "The guideline states that patient education is aimed at an informed and empowered patient/caregiver who is less fearful and this results in better treatment outcomes[cite: 123].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0333",
    "Questions": "What is the definition of Pulmonary Tuberculosis (PT?",
    "A": "TB involving only the lung tissue.",
    "B": "TB involving the lung tissue, airways or draining lymph nodes",
    "C": "TB involving only the intrathoracic lymph nodes.",
    "D": "TB involving organs other than the lungs.",
    "Answer": "B",
    "Comment": "Pulmonary tuberculosis (PT refers to TB involving the lung tissue airways or draining lymph nodes[cite: 54]. airways or draining lymph nodes[cite: 54].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0334",
    "Questions": "What is the recommended duration of the continuation phase for a child with severe PTB and most EPTB?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "B",
    "Comment": "For severe PTB and most EPTB the continuation phase duration is 4 months[cite: 142].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0335",
    "Questions": "What is the purpose of U-LAM testing in children living with HIV (CLHIV)?",
    "A": "To test for drug resistance.",
    "B": "To assess for drug-susceptible TB.",
    "C": "To diagnose advanced HIV disease.",
    "D": "The guideline does not mention U-LAM.",
    "Answer": "B",
    "Comment": "U-LAM is listed under 'Special investigations' in Figure 2 in the box for assessing for TB infection or TB disease[cite: 62].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0336",
    "Questions": "Which of the following is a definition of a drug-susceptible TB (DS-T?",
    "A": "M.tb strains that are resistant to first-line agents.",
    "B": "M.tb strains that are susceptible to first-line agents rifampicin and isoniazid.",
    "C": "Any patient with TB involving organs other than the lungs.",
    "D": "The form of TB that requires the longest treatment regimen.",
    "Answer": "B",
    "Comment": "Drug-susceptible TB (DS-T is defined as M.tb strains that are susceptible to the first-line agents rifampicin and isoniazid[cite: 56].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "Paeds0337",
    "Questions": "In anaphylaxis in a child, the recommended initial route and dose of adrenaline (epinephrine) is:",
    "A": "IV 0.1 mL/kg of 1:10 000",
    "B": "IM 0.01 mL/kg of 1:1000",
    "C": "SC 0.02 mL/kg of 1:1000",
    "D": "Oral 0.01 mL/kg of 1:1000",
    "Answer": "B",
    "Comment": "IM adrenaline 1:1000 at 0.01 mL/kg (10 ?g/kg) is first-line; do not give IV initially.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0338",
    "Questions": "Maximum single IM dose of adrenaline for anaphylaxis per the guideline is:",
    "A": "0.2 mL",
    "B": "0.5 mL",
    "C": "1.0 mL",
    "D": "2.0 mL",
    "Answer": "B",
    "Comment": "The guideline states a max per IM dose of 0.5 mL (1:1000).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0339",
    "Questions": "If a child fails to respond to several IM doses of adrenaline in anaphylaxis, the guideline next recommends:",
    "A": "Nebulised adrenaline only",
    "B": "Start IV adrenaline infusion (very low dose)",
    "C": "Give high-dose IV hydrocortisone only",
    "D": "Wait and observe for biphasic reaction",
    "Answer": "B",
    "Comment": "IV infusion may be used if IM doses fail; guideline gives an IV infusion rate example.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0340",
    "Questions": "For maintenance of arterial oxygen saturation �95% in severe anaphylaxis the guideline recommends:",
    "A": "Nasal prongs at 0.5 L/min",
    "B": "Face mask with reservoir at 15 L/min",
    "C": "Simple face mask at 2 L/min",
    "D": "No supplemental oxygen unless hypoxic",
    "Answer": "B",
    "Comment": "Severe anaphylaxis requires high-flow oxygen via facemask with reservoir (�15 L/min).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0341",
    "Questions": "In ETAT triage, which of the following is a sign mandating immediate emergency treatment (category ?Emergency?)?",
    "A": "Mild cough only",
    "B": "Cold hands with capillary refill �3 seconds and weak fast pulse",
    "C": "Isolated low-grade fever (37.8�C)",
    "D": "History of mild diarrhoea without dehydration",
    "Answer": "B",
    "Comment": "These are ETAT emergency circulation signs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0342",
    "Questions": "Per ETAT, which infant is automatically a priority (place ahead of queue)?",
    "A": "7-month-old with mild rhinorrhoea",
    "B": "Infant < 3 months old presenting to facility",
    "C": "10-year-old with controlled asthma",
    "D": "Teenager with controlled epilepsy",
    "Answer": "B",
    "Comment": "Young infant (<3 months) is a priority sign in ETAT.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0343",
    "Questions": "During paediatric resuscitation, if chest rise is inadequate with bag-mask ventilation, the guideline advises to first:",
    "A": "Intubate immediately without further checks",
    "B": "Reassess airway patency and reposition airway / insert oropharyngeal airway",
    "C": "Give a fluid bolus before adjusting airway",
    "D": "Give sodium bicarbonate",
    "Answer": "B",
    "Comment": "Adjust airway position and consider airway adjuncts before intubation.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0344",
    "Questions": "In cardiorespiratory arrest, the recommended oxygen flow via bag-valve mask is:",
    "A": "1?2 L/min",
    "B": "6?10 L/min only",
    "C": "Connect to high-flow oxygen (�15 L/min)",
    "D": "No oxygen required during initial ventilation",
    "Answer": "C",
    "Comment": "Bag-valve-mask ventilation should be connected to high-flow oxygen (�15 L/min).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0345",
    "Questions": "The PAWPER tape is used to:",
    "A": "Measure blood pressure in neonates",
    "B": "Estimate weight considering body habitus",
    "C": "Calculate oxygen requirements only",
    "D": "Assess capillary refill time",
    "Answer": "B",
    "Comment": "PAWPER tape accounts for body habitus to estimate weight.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0346",
    "Questions": "For severe acute malnutrition stabilisation feeding, the guideline prescribes F75 at:",
    "A": "50 mL/kg/day",
    "B": "130 mL/kg/day",
    "C": "200 mL/kg/day from the start",
    "D": "10 mL/kg/day",
    "Answer": "B",
    "Comment": "F75 stabilisation feed is given at 130 mL/kg/day, divided into 3-hourly feeds.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0347",
    "Questions": "During the transition/rehabilitation phase for severe malnutrition the guideline recommends F100; the target approximate total volume is:",
    "A": "~100 mL/kg/day",
    "B": "~130 mL/kg/day",
    "C": "~200 mL/kg/day",
    "D": "No oral feeds allowed",
    "Answer": "C",
    "Comment": "Rehabilitation (F100) volumes to ~200 mL/kg/day for rebuilding/catch-up.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0348",
    "Questions": "The guideline?s advice about starting iron in severely malnourished children is to:",
    "A": "Start iron immediately on admission",
    "B": "Never give iron to malnourished children",
    "C": "Delay iron until appetite returns and weight gain begins (usually week 2)",
    "D": "Give large bolus IV iron on day 1",
    "Answer": "C",
    "Comment": "Do not give iron initially; begin once gaining weight and oedema resolve",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0349",
    "Questions": "If a severely malnourished child has symptomatic anaemia (e.g., Hb ~3 g/dL), the guideline recommends:",
    "A": "No transfusion; give oral iron only",
    "B": "Packed red cells 5 mL/kg IV over 3 hours + furosemide 1 mg/kg at start",
    "C": "Immediate rapid bolus 20 mL/kg packed cells over 15 min",
    "D": "Exchange transfusion only",
    "Answer": "B",
    "Comment": "Blood transfusion is given cautiously: 5 mL/kg over 3 hours with furosemide.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0350",
    "Questions": "For diarrhoea in children, the guideline advises routine use of antibiotics:",
    "A": "Yes ? for all diarrhoea cases",
    "B": "No ? antibiotics are not routinely used for diarrhoea",
    "C": "Only loperamide is first-line",
    "D": "Always use metronidazole first-line",
    "Answer": "B",
    "Comment": "Antibiotics are not routine; used selectively (e.g., dysentery, cholera, severe cases).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0351",
    "Questions": "WHO-style ORS rehydration per guideline for a non-shocked child with severe dehydration is:",
    "A": "10 mL/kg over 1 hour",
    "B": "80 mL/kg over 4 hours by frequent small sips (or NGT alternative)",
    "C": "200 mL/kg over 2 hours",
    "D": "No ORS; IV only",
    "Answer": "B",
    "Comment": "ORS 80 mL/kg over 4 hours is recommended for severe/some dehydration if not shocke",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0352",
    "Questions": "In shock (non-malnourished child), the guideline recommends initial fluid bolus of:",
    "A": "5 mL/kg over 60 minutes",
    "B": "Sodium chloride 0.9% 10 mL/kg over 20 minutes (repeat as needed)",
    "C": "Ringer?s lactate 100 mL/kg immediately",
    "D": "No fluids, start dopamine immediately",
    "Answer": "B",
    "Comment": "Initial shock bolus 10 mL/kg over 20 minutes, reassess and repeat as neede",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0353",
    "Questions": "In a child with severe malnutrition and shock, the guideline suggests caution and recommends:",
    "A": "No fluid boluses at all",
    "B": "Sodium chloride 0.9% 10 mL/kg over 20 minutes; up to 4 boluses may be given with frequent reassessment",
    "C": "Rapid 20 mL/kg boluses repeated without limit",
    "D": "Use albumin as first-line fluid bolus",
    "Answer": "B",
    "Comment": "Shock treatment in malnutrition is cautious: 10 mL/kg with up to 4 boluses, monitor for overloa",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0354",
    "Questions": "For cholera or epidemic diarrhoea the guideline advises:",
    "A": "Routine antimotility agents for all ages",
    "B": "Treat according to susceptibilities of organisms in current epidemics",
    "C": "Always give ciprofloxacin irrespective of context",
    "D": "Avoid ORS entirely",
    "Answer": "B",
    "Comment": "Cholera management depends on current epidemic susceptibilities.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0355",
    "Questions": "The guideline recommends zinc supplementation for all children with diarrhoea at what dose?",
    "A": "2 mg/day for 7 days",
    "B": "10 mg/day for 14 days",
    "C": "50 mg/day for 5 days",
    "D": "No zinc recommended",
    "Answer": "B",
    "Comment": "Zinc elemental 10 mg/day for 14 days is recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0356",
    "Questions": "For suspected shigella dysentery, the guideline lists which of the following options?",
    "A": "Ceftriaxone IV 100 mg/kg once daily for 5 days OR ciprofloxacin oral 15 mg/kg 12-hourly for 3 days",
    "B": "Amoxicillin only for 3 days",
    "C": "Metronidazole only",
    "D": "No antibiotics ever for dysentery",
    "Answer": "A",
    "Comment": "Those are the dysentery treatment options liste",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0357",
    "Questions": "In pneumonia (non-severe) the guideline recommends which empiric antibiotic?",
    "A": "Amoxicillin oral 45 mg/kg/dose 12 hourly for 5 days",
    "B": "Azithromycin only once",
    "C": "No antibiotics ? supportive care only",
    "D": "Vancomycin IV 15 mg/kg 6 hourly",
    "Answer": "A",
    "Comment": "Non-severe pneumonia: oral amoxicillin 45 mg/kg twice daily for 5 days.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0358",
    "Questions": "For severe or very severe pneumonia, initial IV therapy per guideline is:",
    "A": "Oral amoxicillin only",
    "B": "Amoxicillin/clavulanate IV 25 mg/kg (amoxicillin component) 8 hourly",
    "C": "Erythromycin oral only",
    "D": "Ciprofloxacin IV 50 mg/kg 4 hourly",
    "Answer": "B",
    "Comment": "Severe pneumonia: IV amoxicillin/clavulanate at that dose; limit clavulanate exposure.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0359",
    "Questions": "If pneumonia is suspected to be due to Mycoplasma, the guideline suggests:",
    "A": "Start high-dose penicillin only",
    "B": "Consider macrolide therapy such as azithromycin",
    "C": "Give amphotericin B",
    "D": "Macrolides are contraindicated",
    "Answer": "B",
    "Comment": "Mycoplasma/atypical pneumonias are treated with macrolide (azithromycin).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0360",
    "Questions": "In recurring pneumonia evaluations, the guideline recommends checking for all EXCEPT:",
    "A": "HIV and TB status",
    "B": "Structural lung abnormality or immune deficiency",
    "C": "Repeated use of inhaled bronchodilators as sole cause",
    "D": "Possible foreign body aspiration",
    "Answer": "C",
    "Comment": "While bronchodilator overuse isn't the investigation target per se, the guideline emphasizes TB, HIV, structural causes, foreign body.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0361",
    "Questions": "For bronchiolitis, which management is recommended by the guideline?",
    "A": "Routine antibiotics and steroids for all cases",
    "B": "Nebulised ?2-agonist trial; reserve chest X-ray for severe/complicated cases",
    "C": "Immediate intubation for all infants <2 years",
    "D": "Routine chest X-ray in all mild cases",
    "Answer": "B",
    "Comment": "Bronchiolitis: consider bronchodilator trial if wheeze; CXR reserved for severe cases.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0362",
    "Questions": "Tachypnoea cutoff for pneumonia diagnosis in a 3-month-old (2?12 months) according to the guideline is:",
    "A": ">40 breaths/min",
    "B": ">50 breaths/min",
    "C": ">60 breaths/min",
    "D": ">30 breaths/min",
    "Answer": "B",
    "Comment": "For 2?12 months tachypnoea >50/min is the threshol",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0363",
    "Questions": "For acute febrile seizures (not complex) initial acute management per guideline includes:",
    "A": "Immediate long-term antiepileptic therapy",
    "B": "Supportive measures and treat fever; only treat prolonged seizures as status epilepticus",
    "C": "Always perform lumbar puncture immediately",
    "D": "Immediate phenobarbitone prophylaxis for recurrence prevention in every child",
    "Answer": "B",
    "Comment": "Febrile seizures typically need supportive care; prolonged seizures require active anticonvulsant therapy.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0364",
    "Questions": "In status epilepticus (convulsive), the guideline lists initial IV anticonvulsant of choice as:",
    "A": "Phenobarbitone 20 mg/kg as single IV dose (or IM/oral alternative if IV not available)",
    "B": "Phenytoin 50 mg/kg orally",
    "C": "Diazepam oral only",
    "D": "Sodium valproate first-line for all children immediately",
    "Answer": "A",
    "Comment": "Phenobarbitone 20 mg/kg IV is presented as an option where indicate",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0365",
    "Questions": "The correction formula for hyponatraemia fluid calculation in the guideline uses volume = (130 ? Na) ? body weight ? 4 (mL). This is applied for:",
    "A": "Severe symptomatic hyponatraemia requiring controlled correction",
    "B": "Chronic hypertension management",
    "C": "Calculating ORS volumes only",
    "D": "Estimating maintenance glucose needs",
    "Answer": "A",
    "Comment": "The guideline provides formula for calculating sodium chloride volume in significant hyponatraemi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0366",
    "Questions": "For acute severe malnutrition, hypoglycaemia (blood glucose <3 mmol/L) in asymptomatic child is treated with:",
    "A": "IV bolus Dextrose 50% 5 mL/kg immediately",
    "B": "Stabilisation/F75 formula oral 15 mL/kg OR Dextrose 10% oral 10 mL/kg (if asymptomatic)",
    "C": "No treatment necessary",
    "D": "IV Dextrose 50% 10 mL/kg IM injection",
    "Answer": "B",
    "Comment": "Guideline recommends oral F75 or dextrose 10% oral for asymptomatic hypoglycaemia; IV 10% 5 mL/kg if symptomati",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0367",
    "Questions": "In severe malnutrition, which of the following is TRUE about IV fluids?",
    "A": "Start large-volume IV infusions as in healthy children without caution",
    "B": "Avoid IV infusions if possible; treat dehydration carefully due to poor cardiac reserve",
    "C": "Use albumin routinely for rehydration",
    "D": "Give potassium immediately on admission to all children",
    "Answer": "B",
    "Comment": "Children with severe malnutrition have poor cardiac reserves?avoid IV fluids when possible and reassess frequently.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0368",
    "Questions": "According to the guideline, which of these is an immediate life-threatening anaphylactic sign?",
    "A": "Mild urticaria only",
    "B": "Upper airway obstruction with stridor and hypotension",
    "C": "Itching alone with normal vitals",
    "D": "Isolated diarrhoea without respiratory compromise",
    "Answer": "B",
    "Comment": "Stridor with airway compromise and hypotension are life-threatening.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0369",
    "Questions": "In anaphylaxis, steroids (e.g., hydrocortisone) are recommended as:",
    "A": "First-line sole therapy",
    "B": "Adjunctive therapy only?not first line?e.g., hydrocortisone IV 5 mg/kg 4?6 hourly for 12?24 h",
    "C": "Contraindicated entirely",
    "D": "Given instead of adrenaline in mild cases",
    "Answer": "B",
    "Comment": "Steroids are adjuncts and not first-line; guideline gives dose range.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0370",
    "Questions": "For stridor associated with anaphylaxis the guideline suggests nebulised adrenaline (1:1000) every:",
    "A": "5?10 minutes continuously",
    "B": "15?30 minutes until obstruction abolished",
    "C": "Once only on arrival",
    "D": "Every 6 hours only",
    "Answer": "B",
    "Comment": "Nebulised adrenaline 1:1000 diluted as stated every 15?30 minutes for stridor.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0371",
    "Questions": "Which statement regarding observation after anaphylaxis is recommended?",
    "A": "Discharge immediately once symptoms subside",
    "B": "Observe for 24 hours because of risk of biphasic reactions",
    "C": "No observation needed after IM adrenaline",
    "D": "Observe for 1 hour only irrespective of severity",
    "Answer": "B",
    "Comment": "Guideline advises observation for 24 hours to watch for biphasic reactions.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0372",
    "Questions": "Per the guideline, in a child with pneumonia and empyema suspected due to S. aureus, you should suspect S. aureus especially when:",
    "A": "Only mild cough present",
    "B": "Empyema, pulmonary cavitation, pneumatocoele formation, or extrapulmonary pyogenic infections present",
    "C": "Tachycardia only without respiratory signs",
    "D": "Viral prodrome only",
    "Answer": "B",
    "Comment": "Those features point to staphylococcal pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0373",
    "Questions": "Which of the following antibiotics and dosing is recommended for severe malnutrition with suspected sepsis?",
    "A": "Ampicillin IV 50 mg/kg 6 hourly PLUS gentamicin IV 6 mg/kg once daily for 5 days",
    "B": "Amoxicillin oral only for 3 days",
    "C": "Ciprofloxacin IV 100 mg/kg for 1 day",
    "D": "No antibiotics ? only nutritional support",
    "Answer": "A",
    "Comment": "Guideline lists ampicillin + gentamicin for severe malnutrition/sepsis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0374",
    "Questions": "Gentamicin dosing recommended in many paediatric severe infections (single daily dose) per guideline is:",
    "A": "1 mg/kg/day",
    "B": "3 mg/kg/day",
    "C": "6 mg/kg/day as a single daily dose",
    "D": "20 mg/kg/day",
    "Answer": "C",
    "Comment": "Gentamicin 6 mg/kg is cited as single daily dose in several indications.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0375",
    "Questions": "For typhoid fever, the guideline recommends ceftriaxone IV at:",
    "A": "10 mg/kg once daily for 3 days",
    "B": "100 mg/kg once daily for 10?14 days",
    "C": "50 mg/kg twice daily for 1 day only",
    "D": "Oral amoxicillin only for 2 days",
    "Answer": "B",
    "Comment": "Ceftriaxone 100 mg/kg IV once daily for 10?14 days for typhoid is specifie",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0376",
    "Questions": "The guideline recommends routine chest X-ray for pneumonia in which situation?",
    "A": "All outpatient mild pneumonia cases",
    "B": "Only when failure to respond to therapy, severe disease with suspected complications or for admissions",
    "C": "Never do chest X-ray for children",
    "D": "Only for neonates < 1 week old",
    "Answer": "B",
    "Comment": "CXR reserved for complicated or non-responding cases or admissions.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0377",
    "Questions": "For oxygen therapy in respiratory distress (non-critically ill children), the guideline prefers:",
    "A": "No oxygen until intubation",
    "B": "Oxygen at 1?2 L/min humidified by nasal prongs until sat �92% off oxygen",
    "C": "Always use a non-rebreather mask at 15 L/min for every case",
    "D": "Use oxygen only if SaO2 <70%",
    "Answer": "B",
    "Comment": "Nasal prongs 1?2 L/min preferred for many children until resolution (sat �92%).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0378",
    "Questions": "A child with diarrhoea who is breastfeeding should be managed per guideline by:",
    "A": "Stopping breastfeeding temporarily",
    "B": "Continuing breastfeeding and adding ORS in addition to feeds",
    "C": "Replacing breast milk entirely with ORS",
    "D": "Giving only solid foods and no fluids",
    "Answer": "B",
    "Comment": "Continue breastfeeds; give ORS in addition for rehydration.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0379",
    "Questions": "Which of these medications is explicitly stated as having no role in routine management of acute diarrhoea?",
    "A": "ORS",
    "B": "Zinc supplementation",
    "C": "Loperamide (antidiarrhoeal)",
    "D": "Continued feeding",
    "Answer": "C",
    "Comment": "Antidiarrhoeal medications like loperamide are not for routine use.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0380",
    "Questions": "For infants <60 days diagnosed with pneumonia, the guideline diagnostic triggers include:",
    "A": "Only cough without tachypnoea",
    "B": "A general danger sign or lower chest wall indrawing or tachypnoea >60/min",
    "C": "Only fever >37�C",
    "D": "Only rhinorrhoea without other signs",
    "Answer": "B",
    "Comment": "For <60 days, those signs indicate severe disease per guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0381",
    "Questions": "In management of persistent diarrhoea (>14 days), the guideline suggests stepwise diet modification. By day 3?7 you should:",
    "A": "Continue full-strength feeds with additional ORS; change to lactose-free feeds if necessary",
    "B": "Force fasting for 48 hours",
    "C": "Start standard adult antidiarrhoeal drugs",
    "D": "Stop all feeds and only give IV fluids indefinitely",
    "Answer": "A",
    "Comment": "The stepwise protocol includes full-strength feeds, then lactose-free if needed, et",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0382",
    "Questions": "For neonates with hypoglycaemia who are symptomatic, the guideline recommends IV dextrose 10% at:",
    "A": "5 mL/kg IV bolus",
    "B": "50 mL/kg IV bolus",
    "C": "1 mL/kg IV bolus",
    "D": "No IV dextrose; only oral feeds",
    "Answer": "A",
    "Comment": "Symptomatic or persistent hypoglycaemia in malnourished child: Dextrose 10% IV 5 mL/kg.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0383",
    "Questions": "Which is true about the use of promethazine in anaphylaxis per guideline?",
    "A": "It is first-line in children of all ages",
    "B": "Promethazine IV/IM 0.25?0.5 mg/kg/dose is listed but contraindicated in children <2 years old",
    "C": "Promethazine should be given orally only",
    "D": "Promethazine is preferred to antihistamines like chlorphenamine in all cases",
    "Answer": "B",
    "Comment": "Promethazine is contraindicated under 2 years and used with caution otherwise.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0384",
    "Questions": "For suspected severe malaria (P. falciparum) the guideline indicates management in which chapter?",
    "A": "Alimentary tract only",
    "B": "Infectious diseases (Malaria section)",
    "C": "Dermatology chapter",
    "D": "Cardiology chapter",
    "Answer": "B",
    "Comment": "Malaria is covered under Infectious Diseases chapter (Chapter 8).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0385",
    "Questions": "Per the guideline, for severe pneumonia with poor response or nosocomial pneumonia, empiric change includes which combination?",
    "A": "Switch to piperacillin/tazobactam IV 100 mg/kg 8 hourly PLUS amikacin IV 15 mg/kg once daily",
    "B": "Continue oral amoxicillin only",
    "C": "Stop all antibiotics and observe",
    "D": "Give metronidazole only",
    "Answer": "A",
    "Comment": "That regimen is suggested when poor response to first-line and nosocomial pathogens suspecte",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0386",
    "Questions": "For Mycoplasma pneumonia in a severely ill child, initial IV macrolide dosing (azithromycin) per guideline is:",
    "A": "Azithromycin IV 10 mg/kg daily for 2 days (then oral)",
    "B": "Azithromycin oral 1 mg/kg once only",
    "C": "Erythromycin IM 100 mg/kg single dose",
    "D": "Doxycycline first-line in infants <8 years",
    "Answer": "A",
    "Comment": "Guideline suggests IV azithromycin 10 mg/kg daily for 2 days for severe illness then switch to oral.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0387",
    "Questions": "Which of the following is a danger sign in ETAT requiring urgent attention?",
    "A": "Mild irritability only",
    "B": "Restless, continuously irritable or lethargic child",
    "C": "Slow-growing child without acute signs",
    "D": "Single episode of sneezing",
    "Answer": "B",
    "Comment": "Persistent irritability/lethargy are priority signs in ETAT.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0388",
    "Questions": "Per the guideline, which is TRUE about oxygen targets in pneumonia?",
    "A": "Stop oxygen when sat �92% off oxygen",
    "B": "Aim for sat �70% only in children",
    "C": "Oxygen is contraindicated in pneumonia",
    "D": "Aim for sat �99% at all times by any means",
    "Answer": "A",
    "Comment": "Continue oxygen until respiratory distress resolves and saturation �92% off oxygen.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0389",
    "Questions": "Which is correct about amoxicillin dosing for non-severe pneumonia per guideline?",
    "A": "45 mg/kg/dose given once daily for 2 days",
    "B": "45 mg/kg/dose 12 hourly for 5 days",
    "C": "10 mg/kg/dose every 8 hours for 10 days",
    "D": "No amoxicillin is indicated",
    "Answer": "B",
    "Comment": "Amoxicillin 45 mg/kg/dose 12 hourly for 5 days for non-severe pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0390",
    "Questions": "In severe malnutrition, vitamin A dosing per guideline for children 12 months?5 years is:",
    "A": "50,000 IU single dose",
    "B": "200,000 IU single dose",
    "C": "No vitamin A recommended",
    "D": "1,000 IU daily for 1 month",
    "Answer": "B",
    "Comment": "Children 12 months?5 years: 200,000 IU single dose per guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0391",
    "Questions": "For neonatal hypoglycaemia prevention in severe malnutrition, the guideline recommends:",
    "A": "Keep the child NPO for 24 hours",
    "B": "Feed immediately (within 30 minutes) and then ensure every feed given day and night",
    "C": "Give only IV fluids once per day",
    "D": "Delay feeding until day 3",
    "Answer": "B",
    "Comment": "Early feeding is crucial to prevent hypoglycaemia in severe malnutrition.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0392",
    "Questions": "What is the guideline advice regarding chest x-ray in bronchiolitis?",
    "A": "Routine chest x-ray for all bronchiolitis cases",
    "B": "Reserve chest x-ray for clinically severe or complicated bronchiolitis",
    "C": "Never perform chest x-ray under any circumstances",
    "D": "Mandatory CT chest in all infants with bronchiolitis",
    "Answer": "B",
    "Comment": "CXR is reserved for severe/complicated cases in bronchiolitis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0393",
    "Questions": "Per guideline, in children with diarrhoea and persistent hypokalaemia (< normal), supplement with potassium chloride oral dosing is:",
    "A": "125 mg for <6 months; 250 mg for >6 months given 8 hourly",
    "B": "1 g every hour for all ages",
    "C": "No KCl should ever be given in diarrhoea",
    "D": "5000 mg single dose only",
    "Answer": "A",
    "Comment": "KCl dosing per guideline: infants <6 months 125 mg; >6 months 250 mg q8h.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0394",
    "Questions": "In management of severe dehydration with shock, the guideline states that after each bolus you should:",
    "A": "Assume the child is corrected and stop assessment",
    "B": "Reassess for persistence of shock or evidence of circulatory overload before repeating bolus",
    "C": "Always give a total of 10 boluses regardless of response",
    "D": "Immediately start inotropes without reassessment",
    "Answer": "B",
    "Comment": "Reassessment after each bolus is mandated to guide further therapy.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0395",
    "Questions": "Which of the following is recommended as first-line analgesic for discomfort in respiratory disease per guideline?",
    "A": "Paracetamol oral/NGT 15 mg/kg 6 hourly as required",
    "B": "Morphine IV for mild discomfort only",
    "C": "No analgesia permitted in respiratory disease",
    "D": "NSAIDs are always contraindicated",
    "Answer": "A",
    "Comment": "Paracetamol 15 mg/kg 6-hourly is used to relieve discomfort.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0396",
    "Questions": "For meningitis suspicion in severe pneumonia with very ill child, the guideline suggests:",
    "A": "Do nothing; treat only pneumonia",
    "B": "In severe/very severe disease perform blood culture and consider LP where indicated before antibiotics if safe",
    "C": "Always do LP immediately before any resuscitation even if unstable",
    "D": "Only do viral PCR tests and never culture",
    "Answer": "B",
    "Comment": "In severe disease perform blood culture (preferably before antibiotics); LP if indicated and safe.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0397",
    "Questions": "Which is TRUE about dosing of vancomycin for MRSA pneumonia per guideline?",
    "A": "Vancomycin IV 15 mg/kg/dose 6 hourly infused over 1 hour for 14 days",
    "B": "Vancomycin oral 100 mg/kg once daily for 3 days",
    "C": "Vancomycin is not effective for MRSA",
    "D": "Vancomycin given IM only",
    "Answer": "A",
    "Comment": "This IV vancomycin dosing is specified for MRSA pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0398",
    "Questions": "For acute management of suspected sepsis in a very young infant <2 months, guideline empiric antibiotics include:",
    "A": "Oral amoxicillin only",
    "B": "Ampicillin IV 25?50 mg/kg 6 hourly PLUS gentamicin IV 6 mg/kg once daily for 5 days",
    "C": "Ceftriaxone alone PO for 2 days",
    "D": "No antibiotics until culture positive",
    "Answer": "B",
    "Comment": "Neonatal sepsis empiric coverage includes ampicillin + gentamicin.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0399",
    "Questions": "Which of the following is an ETAT priority sign (place ahead of normal queue)?",
    "A": "Temperature 36.8�C and active play",
    "B": "Severe pallor or trauma",
    "C": "History of mild cough for 1 day only",
    "D": "Routine immunisation visit",
    "Answer": "B",
    "Comment": "Severe pallor and trauma are ETAT priority signs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0400",
    "Questions": "Per the guideline, the first step in treatment of shock is:",
    "A": "Give antibiotics first then fluids",
    "B": "Reassess airway/breathing and call for help; then give fluid bolus as needed",
    "C": "Immediate CT scan before any treatment",
    "D": "Begin enteral feeding only",
    "Answer": "B",
    "Comment": "Always call for help and begin resuscitative measures including appropriate fluid bolus.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0401",
    "Questions": "Which statement about measurements of medication levels does the guideline recommend?",
    "A": "Routine measurement for all medications in all patients",
    "B": "Monitor only when there is a specific clinical question (e.g., narrow therapeutic index, toxicity suspicion)",
    "C": "Therapeutic drug monitoring is useless and discouraged",
    "D": "Levels must be measured daily for paracetamol in all children",
    "Answer": "B",
    "Comment": "Therapeutic drug monitoring should be tailored to answer a clinical question.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0402",
    "Questions": "Which is TRUE regarding prescription writing in children per the guideline?",
    "A": "Abbreviations and decimal points are encouraged for speed",
    "B": "Prescriptions should include generic name, route, dose, frequency, duration, and child's weight/age",
    "C": "Do not include the prescriber?s contact details",
    "D": "Use Greek mu (�) for micrograms to save space",
    "Answer": "B",
    "Comment": "Guideline emphasizes full, clear prescription details including weight and prescriber info.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0403",
    "Questions": "In paediatric DKA management (chapter present in guideline), which of the following is typically a key concern mentioned?",
    "A": "Cerebral oedema risk during rehydration and insulin therapy",
    "B": "No risk of electrolyte disturbance",
    "C": "Rapid bolus insulin recommended at 1 U/kg IV immediately",
    "D": "Always withhold potassium irrespective of levels",
    "Answer": "A",
    "Comment": "Cerebral oedema is a major complication to consider in DKA; manage fluids/insulin cautiously.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0404",
    "Questions": "Regarding neonatal jaundice (unconjugated hyperbilirubinaemia), the guideline is likely to recommend:",
    "A": "Immediate exchange transfusion for any bilirubin level regardless of age/gestation",
    "B": "Use of phototherapy and age/weight-adjusted thresholds for exchange transfusion",
    "C": "No treatment is ever necessary for neonatal jaundice",
    "D": "Use of antibiotics as first-line therapy",
    "Answer": "B",
    "Comment": "Standard neonatal jaundice management includes phototherapy and exchange per thresholds (chapter on newborns).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0405",
    "Questions": "For management of seizures in neonates, guideline dosing for phenobarbitone single IV dose is:",
    "A": "5 mg/kg",
    "B": "20 mg/kg as single IV dose",
    "C": "100 mg/kg",
    "D": "0.5 mg/kg only",
    "Answer": "B",
    "Comment": "Phenobarbitone IV 20 mg/kg as a loading dose is recommended for neonatal seizures.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0406",
    "Questions": "Which of the following is a sign of severe dehydration per ETAT/diarrhoea chapter?",
    "A": "Sunken eyes, lethargy, very slow skin pinch (>2 sec) with Fluid loss plus two features",
    "B": "Mild thirst only",
    "C": "Normal skin turgor and active play",
    "D": "Slight dry lips only",
    "Answer": "A",
    "Comment": "Severe dehydration is fluid loss plus two features like lethargy, sunken eyes, slow skin pinch.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0407",
    "Questions": "Per the guideline, in children with pneumonia the presence of hypoxia or hypercapnia indicates:",
    "A": "No further care needed",
    "B": "Indication for ventilatory support",
    "C": "Immediate discharge home",
    "D": "Give only oral analgesia",
    "Answer": "B",
    "Comment": "Hypoxia (SATS monitor) or hypercapnia (blood gas) indicate ventilatory support requirement.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0408",
    "Questions": "In management of persistent diarrhoea, the guideline lists semi-elemental formula as appropriate during which days?",
    "A": "Day 0 only",
    "B": "Day 8?13 as a step when earlier steps have failed",
    "C": "Never indicated",
    "D": "Only in adults",
    "Answer": "B",
    "Comment": "Semi-elemental formula (sucrose- and lactose-free) is suggested in day 8?13 step.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0409",
    "Questions": "According to the guideline, which of these is NOT recommended to routinely give to children with acute watery diarrhoea?",
    "A": "ORS and continued feeding",
    "B": "Zinc supplementation",
    "C": "Antiemetics and antimotility drugs like loperamide routinely",
    "D": "Counselling on feeding and follow-up",
    "Answer": "C",
    "Comment": "Antidiarrhoeal drugs and routine antiemetics are not recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0410",
    "Questions": "For a child with severe pneumonia and suspected MRSA, the guideline recommends adding which agent?",
    "A": "Vancomycin IV 15 mg/kg/dose 6 hourly",
    "B": "Oral amoxicillin only",
    "C": "Metronidazole only",
    "D": "Isoniazid prophylaxis immediately",
    "Answer": "A",
    "Comment": "Vancomycin is recommended for confirmed MRSA pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0411",
    "Questions": "Which of the following is recommended for supportive care in pneumonia per guideline?",
    "A": "Bed rest, clear nasal/oral secretions, monitor vitals including SaO2 and hydration",
    "B": "Routine immediate chest physiotherapy for all children",
    "C": "No monitoring required if child seems well",
    "D": "Isolate and withhold feeding permanently",
    "Answer": "A",
    "Comment": "These supportive measures are recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0412",
    "Questions": "Which is TRUE about enteral feeding in children with respiratory distress per guideline?",
    "A": "If RR >60/min, consider small frequent feeds via oro/nasogastric tube or IV fluids if enteral feeds not tolerated",
    "B": "Stop all enteral feeds permanently if RR >40/min",
    "C": "Always feed large boluses by mouth irrespective of RR",
    "D": "Enteral feeding contraindicated in all respiratory diseases",
    "Answer": "A",
    "Comment": "Maintain nutrition; consider NGT feeds if high RR or intolerance.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0413",
    "Questions": "Which of the following is an appropriate sodium chloride bolus for initial resuscitation of dehydrating watery diarrhoea in children (non-malnourished) per guideline?",
    "A": "1 mL/kg over 1 minute",
    "B": "Sodium chloride 0.9% IV 10 mL/kg given as a bolus over 20 minutes (if shock)",
    "C": "100 mL/kg bolus immediately for all children",
    "D": "No saline bolus, use dopamine first",
    "Answer": "B",
    "Comment": "Initial bolus 10 mL/kg over 20 minutes for shock is recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0414",
    "Questions": "In paediatric intensive care vasopressor/inotrope table, low-dose adrenaline infusion may be used for:",
    "A": "Symptomatic bradycardia unresponsive to atropine and for shock with low CO/low SVR",
    "B": "Always first-line for hypertension only",
    "C": "Analgesia adjunct only",
    "D": "Not indicated in shock management",
    "Answer": "A",
    "Comment": "Adrenaline is indicated for low CO/low SVR shock and symptomatic bradycardi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0415",
    "Questions": "Which iv concentration is given in the guideline for vasopressor adrenaline infusion preparation?",
    "A": "1 ?g/mL only",
    "B": "100 ?g/mL (5 mg in 50 mL normal saline)",
    "C": "1000 ?g/mL in 10 mL saline always",
    "D": "No recommended concentration presented",
    "Answer": "B",
    "Comment": "The guideline gives concentration: adrenaline 100 ?g/mL (5 mg in 50 mL NS).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0416",
    "Questions": "Which of the following best describes the guideline?s stance on patient adherence in chronic paediatric conditions?",
    "A": "Adherence is unimportant in chronic conditions",
    "B": "Adherence must be assessed regularly with a multi-method approach (including self-report) and simplified regimens are preferred",
    "C": "Never change regimens based on adherence concerns",
    "D": "Adherence is only the caregiver?s responsibility and not discussed with the child",
    "Answer": "B",
    "Comment": "The guideline emphasizes assessing adherence and simplifying regimens to improve it.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0417",
    "Questions": "Which is recommended about prescription frequency wording?",
    "A": "Use qid, tid abbreviations for speed",
    "B": "Avoid Greek/Roman frequency abbreviations; state frequency in hours or times per day (e.g., ?8 hourly? or ?3 times daily?)",
    "C": "Always write in Latin abbreviations only",
    "D": "Frequency can be omitted if dose is obvious",
    "Answer": "B",
    "Comment": "The guideline recommends avoiding abbreviations and writing frequency clearly.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0418",
    "Questions": "Which of the following is emphasized about formulation selection in the EML?",
    "A": "Always prescribe brand names to ensure clarity",
    "B": "The EML is provided at generic (INN) level; local formularies select preferred members of classes based on tender/pricing",
    "C": "Choose the most expensive drug always",
    "D": "Do not consult local formularies?use this book only",
    "Answer": "B",
    "Comment": "The EML lists INNs; local formularies specify preferred agents.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0419",
    "Questions": "Which of the following is TRUE about measuring aminoglycoside levels per guideline?",
    "A": "Peak and trough levels can help identify dosing adequacy and toxicity risk; troughs before next dose are valuable",
    "B": "Levels are never useful and should not be measured",
    "C": "Only peaks are useful, troughs are irrelevant",
    "D": "Aminoglycosides are safe in renal impairment without monitoring",
    "Answer": "A",
    "Comment": "The guideline notes trough levels help detect potential toxicity; aminoglycosides contraindicated in renal impairment without caution/monitoring.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0420",
    "Questions": "Which of these is an advised step before prescribing a new medicine for chronic disease, per the adherence guidance?",
    "A": "Do not tell the patient purpose or possible side effects",
    "B": "Establish the patient?s daily routine, occupation, and preferences to adapt dosing times and reduce regimen complexity",
    "C": "Prescribe complex multiple dosing schedules by default",
    "D": "Blame the patient if they fail to adhere",
    "Answer": "B",
    "Comment": "The guideline advocates tailoring regimens to patient?s routine to improve adherence.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0421",
    "Questions": "Which of the following statements regarding antibiotic use during diarrhoea is correct per guideline?",
    "A": "Oral antibiotics for systemic action are best given parenterally when absorption may be impaired by diarrhoea",
    "B": "Give oral antibiotics always for systemic infections irrespective of absorption concerns",
    "C": "Avoid parenteral antibiotics in all children with diarrhoea",
    "D": "Antibiotics are first-line for all watery diarrhoea",
    "Answer": "A",
    "Comment": "Diarrhoea may impair absorption; parenteral route preferred for systemic effect.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0422",
    "Questions": "Which of the following steps is part of the 10-step inpatient management of severe acute malnutrition?",
    "A": "Hypoglycaemia, hypothermia, dehydration, electrolytes, infection, micronutrients, stabilisation feeding, catch-up growth, sensory stimulation, prepare for follow up",
    "B": "Immediate high-volume IV fluids then discharge",
    "C": "No monitoring of weight until 6 months",
    "D": "Only give vitamin C and no other nutrients",
    "Answer": "A",
    "Comment": "The 10-step approach is listed in guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0423",
    "Questions": "Per the guideline, when should nasogastric tube (NGT) feeding be used in the stabilisation phase of severe malnutrition?",
    "A": "When feeds are refused/not finished (<80% intake) or the child is very weak",
    "B": "Never use NGT in malnourished children",
    "C": "Only for adults",
    "D": "For routine use in all children regardless of intake",
    "Answer": "A",
    "Comment": "If feeds <80% or child very weak, NGT feeding is advise",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0424",
    "Questions": "Which of the following is TRUE about referral during an acute anaphylactic episode per guideline?",
    "A": "Patients should be referred immediately during the acute phase regardless of stability",
    "B": "Do not refer during the acute phase; transfer only once patient is stable",
    "C": "Referral is never necessary",
    "D": "Home management is sufficient for severe anaphylaxis always",
    "Answer": "B",
    "Comment": "The guideline cautions against transfer during the acute phase; stabilize first.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0425",
    "Questions": "Which of the following is recommended as a preventive/harm-reduction measure for allergic patients in the guideline?",
    "A": "Provide no education to families",
    "B": "Ensure patients wear allergy identification disc/bracelet and train in self-administered adrenaline auto-injector if appropriate",
    "C": "Never give adrenaline auto-injectors to children",
    "D": "Prescribe only antihistamines for known anaphylaxis history",
    "Answer": "B",
    "Comment": "Allergy ID and training for auto-injector are recommended prevention measures.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0426",
    "Questions": "Which of these medications is recommended for nebulised treatment of associated bronchospasm in anaphylaxis?",
    "A": "Salbutamol nebulised (1 mL salbutamol solution in 3 mL NaCl) at 20-min intervals",
    "B": "Ipratropium only once a week",
    "C": "No bronchodilator should be used",
    "D": "Oral theophylline only",
    "Answer": "A",
    "Comment": "Nebulised salbutamol regimen given for bronchospasm associated with anaphylaxis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0427",
    "Questions": "Which of the following is true about fever triage in ETAT?",
    "A": "Temperature >38�C or <36.4�C in young infant is a priority sign",
    "B": "Fever is never a priority sign",
    "C": "Only temperatures >40�C are significant",
    "D": "All febrile children should be treated as emergencies regardless of other signs",
    "Answer": "A",
    "Comment": "Very high or low temperature in young infants is a priority sign.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0428",
    "Questions": "For treatment of ENT peritonsillar abscess (tonsillitis complicated), the guideline likely recommends:",
    "A": "Conservative management with analgesia only always",
    "B": "Drainage � appropriate antibiotics such as IV amoxicillin/clavulanate depending on severity",
    "C": "No antibiotics and immediate tonsillectomy for all cases",
    "D": "High-dose aspirin for 6 weeks",
    "Answer": "B",
    "Comment": "Complicated tonsillitis (e.g., peritonsillar abscess) requires drainage and targeted antibiotics; see ENT chapter.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0429",
    "Questions": "What is the guideline advice about immediate management of a child with suspected foreign body airway obstruction (inhalation)?",
    "A": "Start chest compressions only and wait for deterioration",
    "B": "Follow airway manoeuvres appropriate to age (back blows/chest thrusts or abdominal thrusts as per paediatric resuscitation algorithms) and call for help",
    "C": "Immediately give bronchodilator only",
    "D": "Give oral fluids to help dislodge object",
    "Answer": "B",
    "Comment": "The emergencies chapter covers foreign body inhalation and standard manoeuvres/advanced resuscitation.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0430",
    "Questions": "In severe malnutrition, the guideline recommends vitamin/mineral supplementation including vitamin A dosing. Which of these is correct for infants <6 months?",
    "A": "Vitamin A 50,000 IU single dose",
    "B": "Vitamin A 200,000 IU single dose",
    "C": "No vitamin A for infants <6 months ever",
    "D": "Vitamin C 100,000 IU daily",
    "Answer": "A",
    "Comment": "Infants <6 months: 50,000 IU single dose per vitamin A dosing table.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0431",
    "Questions": "Which of the following describes the guideline?s approach to oxygen therapy in respiratory distress with hypoxia?",
    "A": "Use humidified nasal prongs 1?2 L/min and continue until sat �92% off oxygen",
    "B": "Immediately proceed to intubation without oxygen trial",
    "C": "Oxygen only if saturations <70%",
    "D": "Discontinue oxygen as soon as patient appears less distressed even if sat <92%",
    "Answer": "A",
    "Comment": "Preferred oxygen delivery is humidified nasal prongs at 1?2 L/min until sat targets met.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0432",
    "Questions": "Which of the following is stated in the EML about essential medicines concept?",
    "A": "Essential medicines must be updated regularly to reflect therapeutic options, resistance patterns and needs",
    "B": "Essential medicines list never changes once published",
    "C": "Only brand-name drugs can be on the EML",
    "D": "EML is only relevant to tertiary hospitals, not primary care",
    "Answer": "A",
    "Comment": "EML concept emphasizes regular updating to reflect changing needs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0433",
    "Questions": "Which of the following is included in the guideline?s recommended basic resuscitation oxygen flows for optimization of oxygen delivery?",
    "A": "High-flow oxygen 15 L/min via facemask with reservoir bag or 6?10 L/min (depending on device)",
    "B": "No oxygen during resuscitation",
    "C": "Only nasal prongs at 0.2 L/min",
    "D": "50 L/min always regardless of device (not specified)",
    "Answer": "A",
    "Comment": "Guideline suggests high-flow oxygen via reservoir mask (~15 L/min) or alternative flows.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0434",
    "Questions": "Which of the following is a correct guideline statement about blood transfusion in severe malnutrition with severe anaemia?",
    "A": "Packed red cells 5 mL/kg over 3 hours plus furosemide 1 mg/kg at start",
    "B": "Give 20 mL/kg rapidly over 15 minutes regardless of condition",
    "C": "Avoid transfusion even if Hb <4 g/dL",
    "D": "Use whole blood only at 50 mL/kg over 30 minutes",
    "Answer": "A",
    "Comment": "That's the recommended transfusion regimen in severe malnutrition with anaemi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0435",
    "Questions": "Which of the following is recommended after discharge of a malnourished child per guideline?",
    "A": "No follow-up needed",
    "B": "Prepare discharge plan: social assessment, link to PHC/follow-up, ensure immunisations up to date, consider RUTF supply if available",
    "C": "Discharge immediately to any caregiver with no instructions",
    "D": "Discontinue vitamins after discharge forever",
    "Answer": "B",
    "Comment": "The guideline details discharge preparation including social and follow-up arrangements.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0436",
    "Questions": "Which of the following best summarises the guideline?s recommendation about phototherapy/exchange transfusion thresholds for neonatal jaundice?",
    "A": "Use fixed bilirubin numbers irrespective of gestational age or risk factors",
    "B": "Use age/weight/clinical-risk adjusted thresholds to decide phototherapy and exchange transfusion (i.e., contextualized thresholds)",
    "C": "Never use phototherapy; always exchange transfuse",
    "D": "Phototherapy is contraindicated in neonates",
    "Answer": "B",
    "Comment": "Neonatal jaundice management uses risk- and age-adjusted thresholds for phototherapy/exchange.",
    "Source": "Paeds EML (2023)"
  }
]